https://curecurrent.com/trials/post-prandial-lipid-effects-of-raltegravir-ral-vs-ritonavir-boosted-darunavir-drv-r-in-anti-retroviral-therapy-art-naive-132316 https://curecurrent.com/trials/immunogenicity-and-safety-of-trivalent-influenza-vaccine-in-pregnant-and-nonpregnant-hiv-uninfected-women-132317 https://curecurrent.com/trials/male-engagement-in-pmtct-services-132318 https://curecurrent.com/trials/alcohol-harm-reduction-intervention-among-female-sex-workers-in-mombasa-kenya-132319 https://curecurrent.com/trials/pilot-placebo-controlled-study-with-lovaza-in-cardiovascular-disease-132320 https://curecurrent.com/trials/safety-and-efficacy-of-salsalate-to-treat-endothelial-dysfunction-in-hiv-infected-adults-132321 https://curecurrent.com/trials/evaluation-of-the-effects-of-a-structural-economic-and-food-security-intervention-on-hiv-vulnerability-in-rural-malawi-132322 https://curecurrent.com/trials/a-group-level-intervention-to-reduce-hiv-sti-risk-for-women-who-have-sex-with-women-in-calgary-and-toronto-132323 https://curecurrent.com/trials/raltegravir-vs-atazanavir-in-combination-with-truvada-for-the-treatment-of-antiretroviral-na-ve-hiv-infected-patients-132324 https://curecurrent.com/trials/mirtazapine-to-reduce-methamphetamine-use-among-msm-with-high-risk-hiv-behaviors-132325 https://curecurrent.com/trials/mid-life-women-preventing-unintended-pregnancy-and-stis-132326 https://curecurrent.com/trials/a-drug-interaction-study-evaluating-plasma-gsk2248761-and-gsk1349572-pharmacokinetics-in-healthy-adult-subjects-132327 https://curecurrent.com/trials/post-marketing-safety-surveillance-program-in-human-immunodeficiency-virus-hiv-infected-children-exposed-to-atazanavir-i-132328 https://curecurrent.com/trials/isolated-anti-hbc-serological-profile-in-hiv-infected-patients-immunological-virological-characteristics-and-response-to-132329 https://curecurrent.com/trials/safety-and-efficacy-of-bay-50-4798-in-patients-with-hiv-infection-132330 https://curecurrent.com/trials/intervention-to-reduce-injection-drug-use-132331 https://curecurrent.com/trials/drug-use-investigation-of-kaletra-tablets-once-daily-administration-on-patients-with-hiv-infection-132332 https://curecurrent.com/trials/levels-of-raltegravir-in-the-female-genital-tissue-132333 https://curecurrent.com/trials/antiretrovirals-and-rate-of-progression-in-carotid-artery-intima-medial-thickness-in-hiv-132334 https://curecurrent.com/trials/a-pilot-raltegravir-versus-nrtis-as-a-backbone-switched-from-a-stable-boosted-pi-regimen-132335 https://curecurrent.com/trials/multi-level-determinants-of-starting-art-late-aim-2-132336 https://curecurrent.com/trials/multi-level-determinants-of-starting-art-late-aim-3-132337 https://curecurrent.com/trials/kaletra-isentress-treatment-evaluation-132338 https://curecurrent.com/trials/diversion-to-treatment-for-injection-drug-users-arrested-for-possession-of-heroin-132339 https://curecurrent.com/trials/reducing-drug-use-and-hiv-risk-in-drug-dependent-adults-arrested-for-prostitution-132340 https://curecurrent.com/trials/evaluating-post-test-hiv-counseling-videos-for-teens-132341 https://curecurrent.com/trials/a-theory-based-hiv-prevention-video-for-rapid-hiv-testing-a-randomized-trial-132342 https://curecurrent.com/trials/frequency-and-clinical-significance-of-renal-and-bone-toxicity-in-hiv-infected-patients-132343 https://curecurrent.com/trials/evaluating-factors-that-impact-loss-to-follow-up-among-postpartum-hiv-infected-women-in-mississippi-132344 https://curecurrent.com/trials/a-clinical-trial-for-people-hiv-age-50-at-risk-for-heart-disease-132345 https://curecurrent.com/trials/ever-tmc-mutation-as-marker-of-the-risk-of-cutaneous-carcinoma-in-immunosuppressed-patients-132346 https://curecurrent.com/trials/evaluation-of-barriers-to-postpartum-care-in-hiv-infected-women-132347 https://curecurrent.com/trials/enhancing-hiv-risk-reduction-among-indian-women-with-risky-husbands-132348 https://curecurrent.com/trials/nurse-delivered-cell-phone-adherence-intervention-pick-it-up-132349 https://curecurrent.com/trials/integrated-infectious-disease-capacity-building-evaluation-132350 https://curecurrent.com/trials/an-educational-and-supportive-counseling-program-for-increasing-antiretroviral-use-and-adherence-in-people-with-hiv-132351 https://curecurrent.com/trials/tenofovir-emtricitabine-efavirenz-and-atazanavir-pharmacokinetics-in-the-aging-hiv-infected-population-132352 https://curecurrent.com/trials/bioavailability-study-of-a-dolutegravir-dispersible-tablet-and-effect-of-different-types-of-water-on-the-dispersible-tab-132353 https://curecurrent.com/trials/atripla-to-raltegravir-switch-study-for-cns-toxicity-132354 https://curecurrent.com/trials/vitamin-d-in-hiv-infected-patients-on-haart-132355 https://curecurrent.com/trials/intermittent-art-in-primary-hiv-infection-132356 https://curecurrent.com/trials/economic-clinical-and-quality-of-life-assessment-in-patients-on-antiretroviral-therapy-132357 https://curecurrent.com/trials/efficacy-and-safety-of-sofosbuvir-plus-ribavirin-in-chronic-genotype-1-2-and-3-hepatitis-c-virus-hcv-and-human-immunodef-132358 https://curecurrent.com/trials/empiric-therapy-of-helminth-co-infection-to-reduce-hiv-1-disease-progression-132359 https://curecurrent.com/trials/switching-undetectables-to-selzentry-132360 https://curecurrent.com/trials/immune-based-therapy-pilot-study-for-the-treatment-of-primary-hiv-infection-phi-imd-132361 https://curecurrent.com/trials/safety-and-immunogenicity-of-13-valent-pneumococcal-conjugate-vaccine-13vpnc-in-hiv-infected-subjects-6-years-of-age-or-132362 https://curecurrent.com/trials/switching-nevirapine-immediate-release-ir-based-regimen-to-nevirapine-extended-release-xr-based-regimen-in-human-immunod-132363 https://curecurrent.com/trials/efavirenz-to-dolutegravir-switch-in-patients-with-cns-toxicity-132364 https://curecurrent.com/trials/omega-3-fatty-acids-for-high-triglycerides-in-hiv-infected-patients-132365 https://curecurrent.com/trials/changes-in-insulin-resistance-in-healthy-volunteers-on-stribild-medication-132366 https://curecurrent.com/trials/a-safety-and-efficacy-study-of-amdoxovir-in-hiv-1-treatment-experienced-subjects-132367 https://curecurrent.com/trials/follow-up-study-to-evaluate-a-non-surgical-device-for-adult-male-circumcision-for-screen-failure-subjects-132368 https://curecurrent.com/trials/feasibility-study-of-prepex-device-when-performed-on-early-infants-children-male-population-by-physicians-132369 https://curecurrent.com/trials/a-phase-4-cross-sectional-study-of-bone-mineral-density-in-hiv-1-infected-subjects-132370 https://curecurrent.com/trials/treatment-effects-of-escitalopram-lexapro-on-generalized-anxiety-disorder-in-patients-with-hiv-and-aids-132371 https://curecurrent.com/trials/epidemiology-of-papillomavirus-infection-hpv-on-infected-women-by-human-immunodeficience-virus-hiv-in-west-indies-and-fr-132372 https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-efficacy-of-tmc435-along-with-pegylated-interferon-alpha-2a-pegasys-and-ri-132373 https://curecurrent.com/trials/hiv-prevention-in-haitian-american-adolescents-132374 https://curecurrent.com/trials/mupirocin-ointment-to-eliminate-nasal-carriage-of-staphylococcus-aureus-in-hiv-infection-132375 https://curecurrent.com/trials/the-effect-of-anti-hiv-treatment-on-body-characteristics-of-hiv-infected-children-132376 https://curecurrent.com/trials/evaluation-of-the-mbio-combined-syphilis-hiv-point-of-care-diagnostic-test-132377 https://curecurrent.com/trials/hiv-patients-illness-perception-and-adherence-132378 https://curecurrent.com/trials/study-targeting-affect-regulation-132379 https://curecurrent.com/trials/stonewall-treatment-evaluation-project-132380 https://curecurrent.com/trials/feasibility-of-a-stigma-reduction-intervention-for-human-immunodeficiency-virus-hiv-infected-women-132381 https://curecurrent.com/trials/couples-in-context-an-rct-of-a-couples-based-hiv-prevention-intervention-132382 https://curecurrent.com/trials/acceptability-of-pharmacologic-treatment-for-methamphetamine-dependence-among-msm-132383 https://curecurrent.com/trials/early-versus-delayed-routine-hiv-testing-in-connecticut-jails-132384 https://curecurrent.com/trials/when-to-start-anti-hiv-drugs-in-patients-with-opportunistic-infections-132385 https://curecurrent.com/trials/early-versus-standard-start-of-anti-hiv-therapy-for-treatment-naive-adults-in-haiti-132386 https://curecurrent.com/trials/suicidality-and-suicide-attempt-among-hiv-patients-on-efavirenz-containing-versus-efavirenz-free-antiretroviral-regimens-132387 https://curecurrent.com/trials/assessing-the-impact-of-an-intervention-to-prevent-intimate-partner-violence-and-hiv-in-uganda-132388 https://curecurrent.com/trials/boceprevir-in-hiv-hcv-coinfected-patients-who-have-failed-to-a-previous-therapy-with-peg-interferon-ribavirin-132389 https://curecurrent.com/trials/chloroquine-for-reducing-immune-activation-in-hiv-infected-individuals-132390 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-etravirine-administered-in-combination-with-other-an-132391 https://curecurrent.com/trials/prenatal-and-postnatal-studies-of-interventions-for-prevention-of-mother-to-child-transmission-132392 https://curecurrent.com/trials/changes-in-lipids-and-safety-of-raltegravir-in-hiv-patients-with-hyperlipidemia-while-on-current-standard-therapy-132393 https://curecurrent.com/trials/hiv-viral-load-monitoring-in-resource-poor-settings-132394 https://curecurrent.com/trials/reducing-hiv-risk-among-episodic-substance-using-men-who-have-sex-with-men-sumsm-132395 https://curecurrent.com/trials/topical-metronidazole-and-miconazole-co-formulated-vaginal-suppositories-for-preventing-vaginal-infections-in-hiv-serone-132396 https://curecurrent.com/trials/efficacy-of-doxycycline-prophylaxis-to-reduce-syphilis-in-high-risk-hiv-positive-msm-132397 https://curecurrent.com/trials/utility-of-urinary-beta2-microglobulin-as-an-early-marker-of-renal-dysfunction-in-vietnamese-hiv-infected-patients-132398 https://curecurrent.com/trials/peginterferon-alpha-2b-and-ribavirin-to-treat-hepatitis-c-in-hiv-infected-patients-132399 https://curecurrent.com/trials/dose-escalation-study-of-the-safety-tolerability-and-pharmacokinetics-of-bilr-355-bs-plus-low-dose-ritonavir-in-hiv-unin-132400 https://curecurrent.com/trials/part-a-drug-interaction-study-of-sofosbuvir-and-antiretroviral-therapy-art-combinations-in-hiv-and-hepatitis-c-virus-hcv-132401 https://curecurrent.com/trials/enhanced-hiv-prevention-in-couples-feasibility-study-3-132402 https://curecurrent.com/trials/choices-teen-a-bundled-risk-reduction-intervention-for-juvenile-justice-females-132403 https://curecurrent.com/trials/hiv-rapid-testing-counseling-in-sexually-transmitted-disease-std-clinics-in-the-u-s-132404 https://curecurrent.com/trials/a-two-way-cross-over-pharmacokinetic-interaction-study-between-raltegravir-and-amlodipine-in-healthy-volunteers-132405 https://curecurrent.com/trials/effects-of-tipranavir-ritonavir-on-the-pharmacokinetic-characteristics-of-triple-drug-nucleoside-and-non-nucleoside-reve-132406 https://curecurrent.com/trials/qualitative-assessment-of-implementing-routine-rapid-hiv-testing-132407 https://curecurrent.com/trials/epidermal-nerve-fiber-density-fat-and-mitochondrial-parameters-in-thai-hiv-patients-on-d4t-and-hiv-patients-132408 https://curecurrent.com/trials/hiv-1-specific-immune-responses-in-thai-individuals-with-hiv-dementia-132409 https://curecurrent.com/trials/establishing-normal-values-for-neuropsychological-testing-in-hiv-negative-thais-132410 https://curecurrent.com/trials/nrti-sparing-pilot-study-132411 https://curecurrent.com/trials/peripheral-reservoir-of-hiv-dna-in-monocytes-pivotal-to-cognition-in-hiv-132412 https://curecurrent.com/trials/effects-of-cyp2b6-genetic-polymorphisms-on-efavirenz-pharmacokinetics-132413 https://curecurrent.com/trials/tipranavir-dose-response-study-using-a-prototype-self-emulsifying-drug-delivery-system-sedds-formulation-in-treatment-na-132414 https://curecurrent.com/trials/hiv-liver-regeneration-project-for-hiv-patients-with-cirrhosis-by-autologous-bone-marrow-transplantation-132415 https://curecurrent.com/trials/validation-of-implementation-of-cervical-dysplasia-treatment-modalities-in-hiv-seropositive-women-132416 https://curecurrent.com/trials/community-based-delivery-of-integrated-family-planning-hiv-testing-and-counseling-services-in-uganda-132417 https://curecurrent.com/trials/clinical-trial-to-assess-the-effect-of-the-change-of-efavirenz-efv-for-lopinavir-ritonavir-lpv-r-in-lipoatrophy-in-hiv-i-132418 https://curecurrent.com/trials/acceptability-of-depo-subq-provera-104-in-uniject-vs-intramuscular-depo-provera-among-hiv-women-providers-uganda-132419 https://curecurrent.com/trials/non-virologic-methods-to-diagnose-treatment-eligibility-in-hiv-exposed-infants-132420 https://curecurrent.com/trials/immune-reconstitution-to-measles-virus-of-hiv-infected-children-in-zambia-132421 https://curecurrent.com/trials/reducing-sexual-risk-behaviors-and-improving-health-for-people-at-a-sexually-transmitted-infection-clinic-132422 https://curecurrent.com/trials/infrared-coagulation-in-preventing-anal-cancer-in-patients-with-hiv-who-have-anal-neoplasia-132423 https://curecurrent.com/trials/tipranavir-and-ritonavir-vs-saquinavir-and-ritonavir-used-with-two-nucleoside-reverse-transcriptase-inhibitors-in-single-132424 https://curecurrent.com/trials/therapeutic-intensification-plus-immunomodulation-to-decrease-the-hiv-1-viral-reservoir-132425 https://curecurrent.com/trials/computer-based-cognitive-behavioral-therapy-for-risky-behaviors-in-opioid-dependent-patients-132426 https://curecurrent.com/trials/exploratory-study-of-tipranavir-and-ritonavir-in-multiple-protease-inhibitor-experienced-hiv-patients-132427 https://curecurrent.com/trials/magnitude-of-the-antibody-response-to-and-safety-of-a-gbs-trivalent-vaccine-in-hiv-positive-and-hiv-negative-pregnant-wo-132428 https://curecurrent.com/trials/visual-inspection-with-acetic-acid-compared-to-lugol-s-iodine-in-hiv-infected-women-132429 https://curecurrent.com/trials/immune-response-to-hpv-vaccine-among-hiv-1-infected-subjects-in-brazil-132430 https://curecurrent.com/trials/the-peercare-study-peer-community-based-assistant-in-retention-132431 https://curecurrent.com/trials/concentrations-of-maraviroc-in-the-semen-of-hiv-infected-men-132432 https://curecurrent.com/trials/raltegravir-and-darunavir-antiretroviral-in-antiretroviral-naive-patients-132433 https://curecurrent.com/trials/pilot-study-to-assess-the-efficacy-of-and-tolerance-to-a-quadruple-therapy-to-treat-hiv-hcv-coinfected-patients-previous-132434 https://curecurrent.com/trials/study-to-determine-the-antiviral-activity-and-safety-of-alovudine-in-nucleoside-experienced-hiv-infected-subjects-experi-132435 https://curecurrent.com/trials/comparative-study-of-three-nnrti-sparing-haart-regimens-132436 https://curecurrent.com/trials/maraviroc-plus-darunavir-ritonavir-for-treatment-na-ve-patients-infected-with-r5-tropic-hiv-1-132437 https://curecurrent.com/trials/pneumococcal-conjugate-vaccine-pcv-in-hiv-infected-children-132438 https://curecurrent.com/trials/acupuncture-and-relaxation-response-for-gi-symptoms-and-hiv-medication-adherence-132439 https://curecurrent.com/trials/effect-of-steady-state-tpv-r-on-intracellular-concentrations-of-zidovudine-and-carbovir-for-patients-with-hiv-132440 https://curecurrent.com/trials/microparticles-vector-of-genetic-information-during-hiv-infection-132441 https://curecurrent.com/trials/sirolimus-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-132442 https://curecurrent.com/trials/bioequivalence-study-of-individual-atazanavir-and-cobicistat-compared-with-atazanavir-in-fixed-dose-combination-with-cob-132443 https://curecurrent.com/trials/alcohol-suicide-and-hiv-prevention-for-teens-in-mental-health-treatment-132444 https://curecurrent.com/trials/anti-hiv-treatment-interruptions-in-hiv-infected-adults-in-south-africa-132445 https://curecurrent.com/trials/pilot-feasibility-trial-of-the-family-strengthening-intervention-in-rwanda-fsi-r-132446 https://curecurrent.com/trials/atazavanir-ritonavir-based-haart-in-children-132447 https://curecurrent.com/trials/a-study-to-assess-the-long-term-safety-and-tolerability-of-tmc114-rtv-in-hiv-1-infected-participants-after-rolling-over-132448 https://curecurrent.com/trials/evaluation-of-atazanavir-substitution-intervention-easi-study-132449 https://curecurrent.com/trials/hiv-hcv-coinfection-impact-of-immune-dysfunction-132450 https://curecurrent.com/trials/directly-observed-therapy-for-community-released-hiv-prisoners-132451 https://curecurrent.com/trials/anti-retrovirals-for-kaposi-s-sarcoma-132452 https://curecurrent.com/trials/study-on-the-impact-of-triptolide-woldifiion-on-hiv-1-reservoir-in-acute-hiv-1-infection-132453 https://curecurrent.com/trials/cotrimoxazole-prophylaxis-in-severely-malnourished-children-132454 https://curecurrent.com/trials/the-effect-of-vitamin-d-supplementation-on-hiv-associated-platelet-hyperreactivity-132455 https://curecurrent.com/trials/effects-of-facility-based-mother-support-groups-on-prevention-of-mother-to-child-transmission-outcomes-in-zimbabwe-132456 https://curecurrent.com/trials/etravirine-pharmacokinetics-and-hiv-viral-load-in-breast-milk-and-plasma-132457 https://curecurrent.com/trials/effects-of-low-dose-maintenance-peg-interferon-alfa-2b-therapy-versus-supportive-care-in-patients-with-cirrhotic-hepatit-132458 https://curecurrent.com/trials/concentrations-of-raltegravir-in-the-semen-of-hiv-infected-men-132459 https://curecurrent.com/trials/mesalamine-to-reduce-t-cell-activation-in-hiv-infection-132460 https://curecurrent.com/trials/effects-of-anti-hiv-drugs-on-the-hepatitis-c-virus-hcv-in-adults-infected-with-both-hcv-and-hiv-132461 https://curecurrent.com/trials/pharmaco-epidemiological-description-of-the-population-treated-with-aptivus-under-market-conditions-safety-efficacy-132462 https://curecurrent.com/trials/preventing-hiv-aids-in-drug-abusing-youth-132463 https://curecurrent.com/trials/a-rollover-study-for-subjects-discontinuing-from-uk-453-061-studies-for-the-treatment-of-hiv-1-132464 https://curecurrent.com/trials/targeted-screening-of-at-risk-adults-for-acute-hiv-1-infection-132465 https://curecurrent.com/trials/study-to-explore-the-effect-of-mefloquine-in-participants-with-progressive-multifocal-leukoencephalopathy-pml-132466 https://curecurrent.com/trials/mfangano-island-healthy-networks-impact-study-132467 https://curecurrent.com/trials/efficacy-and-safety-of-varenicline-among-hiv-infected-patients-132468 https://curecurrent.com/trials/study-to-evaluate-the-activity-and-tolerability-of-lopinavir-ritonavir-and-lamivudine-bitherapy-in-hiv-patients-with-vir-132469 https://curecurrent.com/trials/risk-reduction-for-urban-substance-using-men-who-have-sex-with-men-msm-132470 https://curecurrent.com/trials/interferon-alfa-in-treating-children-with-hiv-related-cancer-132471 https://curecurrent.com/trials/an-adherence-tool-to-manage-narcotic-addicted-hiv-patients-132472 https://curecurrent.com/trials/bioavailability-of-2-different-nevirapine-extended-release-formulations-compared-to-viramune-in-hiv-1-infected-subjects-132473 https://curecurrent.com/trials/treatment-with-nutritional-eating-plan-and-dietary-fibers-in-adult-patients-with-hiv-aids-132474 https://curecurrent.com/trials/a-study-to-assess-the-relative-bioavailability-of-new-tablet-formulations-of-gsk1265744-in-healthy-adult-subjects-132475 https://curecurrent.com/trials/impact-of-switching-to-nnrti-based-therapy-on-the-quality-of-life-of-hiv-infected-patients-with-virological-suppression-132476 https://curecurrent.com/trials/observational-study-with-antiretroviral-treated-patients-switching-to-nevirapine-plus-two-nucleoside-reverse-transcripta-132477 https://curecurrent.com/trials/antiretroviral-activity-and-pharmacokinetics-of-deferiprone-in-healthy-volunteers-and-asymptomatic-hiv-infected-subjects-132478 https://curecurrent.com/trials/long-term-study-in-patients-under-anti-retroviral-combination-therapy-switching-to-viramune-132479 https://curecurrent.com/trials/observational-study-in-patients-with-hiv-infection-type-1-after-switching-to-a-viramune-containing-therapy-regimen-132480 https://curecurrent.com/trials/clinical-and-therapeutic-evaluation-of-the-infection-by-hiv-aids-132481 https://curecurrent.com/trials/comparing-blood-vessel-endothelial-function-in-hiv-infected-people-and-matched-hiv-uninfected-people-132482 https://curecurrent.com/trials/botswana-vitamin-d-supplementation-study-in-hiv-aids-132483 https://curecurrent.com/trials/study-to-determine-the-effects-of-nevirapine-viramune-on-the-steady-state-pharmacokinetics-of-rifabutin-mycobutin-in-hiv-132484 https://curecurrent.com/trials/clotrimazole-vs-mycelex-in-patients-with-human-insufficiency-virus-hiv-infection-for-the-treatment-of-oropharyngeal-cand-132485 https://curecurrent.com/trials/study-of-nevirapine-and-prednisone-to-determine-the-safety-and-effectiveness-in-preventing-nevirapine-associated-rash-in-132486 https://curecurrent.com/trials/investigation-of-the-potential-pharmacokinetic-interaction-between-nevirapine-viramune-and-ethinyl-estradiol-norethindro-132487 https://curecurrent.com/trials/investigation-of-the-potential-pharmacokinetic-interaction-between-nevirapine-abacavir-and-amprenavir-in-hiv-1-infected-132488 https://curecurrent.com/trials/efficacy-of-nevirapine-compared-to-zdv-3tc-administered-in-labor-and-again-at-postdelivery-in-hiv-positive-women-132489 https://curecurrent.com/trials/pharmacokinetic-interaction-between-nevirapine-and-saquinavir-sgc-in-hiv-1-infected-patients-132490 https://curecurrent.com/trials/effects-of-nevirapine-on-the-steady-state-pharmacokinetics-of-fluconazole-in-hiv-positive-patients-132491 https://curecurrent.com/trials/evaluation-of-a-blood-test-to-measure-immune-function-in-hiv-positive-people-compared-with-hiv-negative-people-132492 https://curecurrent.com/trials/development-and-evaluation-of-an-hiv-std-and-pregnancy-prevention-program-for-middle-school-students-132493 https://curecurrent.com/trials/impact-evaluation-study-of-the-faithful-house-programme-on-violence-reduction-in-families-132494 https://curecurrent.com/trials/phase-ii-randomised-controlled-trial-of-memory-work-therapy-at-pasada-tanzania-132495 https://curecurrent.com/trials/randomized-evaluation-of-strategic-intervention-in-multidrug-resistant-patients-with-tipranavir-resist-132496 https://curecurrent.com/trials/tipranavir-ritonavir-vs-genotypically-defined-protease-inhibitor-ritonavir-in-hiv-patients-resist-2-132497 https://curecurrent.com/trials/non-interventional-observational-study-with-viramune-nevirapine-and-various-drug-combinations-in-the-antiretroviral-comb-132498 https://curecurrent.com/trials/spring-safety-efficacy-pharmacokinetics-of-tipranavir-r-in-race-gender-hiv-patients-randomized-to-tdm-or-soc-132499 https://curecurrent.com/trials/a-study-of-tmc278-in-human-immunodeficiency-virus-type-1-infected-patients-who-are-not-treated-with-antiretroviral-medic-132500 https://curecurrent.com/trials/evaluation-of-a-lopinavir-ritonavir-monotherapy-vs-a-triple-therapy-as-maintenance-regimens-in-hiv-1-infected-patients-132501 https://curecurrent.com/trials/an-open-label-trial-of-tmc114-rtv-in-hiv-1-infected-treatment-experienced-subjects-132502 https://curecurrent.com/trials/tmc125-c206-a-phase-iii-study-to-investigate-the-efficacy-tolerability-and-safety-of-tmc125-as-part-of-an-antiretroviral-132503 https://curecurrent.com/trials/a-feasibility-study-to-assess-tenofovir-and-maraviroc-protection-against-hiv-1-in-cervical-and-vaginal-explants-132504 https://curecurrent.com/trials/the-rilpivirine-cerebrospinal-fluid-csf-study-132505 https://curecurrent.com/trials/trial-to-assess-the-lipid-lowering-effect-of-adding-tenofovir-emtricitabine-co-formulation-vs-placebo-to-hiv-1-infected-132506 https://curecurrent.com/trials/study-to-evaluate-the-effect-of-gsk1265744-on-cardiac-conduction-132507 https://curecurrent.com/trials/effects-of-probiotics-on-microbial-translocation-and-immune-activation-markers-in-hiv-positive-patients-on-combined-anti-132508 https://curecurrent.com/trials/web-based-middle-school-hiv-prevention-curricula-aspiring-for-reach-and-impact-132509 https://curecurrent.com/trials/zinc-supplementation-effect-on-immune-recovery-in-hiv-patients-132510 https://curecurrent.com/trials/effectiveness-of-armodafinil-for-treating-fatigue-in-adults-with-hiv-aids-132511 https://curecurrent.com/trials/effect-of-omega-3-fatty-acid-supplementation-on-hypertriglyceridemia-in-hiv-infected-children-132512 https://curecurrent.com/trials/men-of-african-american-legacy-empowering-self-132513 https://curecurrent.com/trials/outcomes-for-antiretroviral-therapy-patients-receiving-palliative-care-132514 https://curecurrent.com/trials/female-upper-genital-tract-in-hiv-infected-women-132515 https://curecurrent.com/trials/study-to-evaluate-the-drug-interaction-between-dolutegravir-dtg-and-daclatasvir-dcv-in-healthy-adult-subjects-132516 https://curecurrent.com/trials/effectiveness-of-opiate-replacement-therapy-administered-prior-to-release-from-a-correctional-facility-1-132517 https://curecurrent.com/trials/efficacy-study-of-different-laboratory-management-strategies-and-drug-regimens-in-hiv-infected-children-in-africa-132518 https://curecurrent.com/trials/vitamin-d-supplementation-and-cd4-count-in-hiv-infected-children-132519 https://curecurrent.com/trials/tipranavir-ritonavir-low-dose-pharmacokinetics-in-treatment-naive-patients-132520 https://curecurrent.com/trials/prevention-for-positives-an-rct-among-vietnamese-hiv-positive-idu-132521 https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-stribild-versus-atripla-in-human-immunodeficiency-virus-type-1-hiv-1-infected-antire-132522 https://curecurrent.com/trials/increasing-hiv-testing-in-urban-emergency-departments-via-mobile-technology-132523 https://curecurrent.com/trials/an-open-label-blinded-assessor-trial-comparing-odor-levels-due-to-different-hygiene-methods-with-prepextm-132524 https://curecurrent.com/trials/hcv-evolution-in-hiv-hcv-genotype-1-coinfected-patients-treated-with-fosamprenavir-132525 https://curecurrent.com/trials/cns-central-nervous-system-viral-dynamics-and-cellular-immunity-during-aids-132526 https://curecurrent.com/trials/effect-of-dolutegravir-on-metformin-pharmacokinetics-in-healthy-adult-subjects-132527 https://curecurrent.com/trials/cohort-field-study-to-assess-the-safety-and-efficacy-of-the-prepex-device-for-non-surgical-circumcision-when-performed-b-132528 https://curecurrent.com/trials/juvenile-detention-to-community-life-132529 https://curecurrent.com/trials/genetic-predictors-of-variability-in-the-drug-drug-interaction-between-darunavir-ritonavir-and-pravastatin-132530 https://curecurrent.com/trials/multi-vitamins-haart-and-hiv-aids-in-uganda-132531 https://curecurrent.com/trials/an-observational-study-to-evaluate-tolerability-of-prezista-or-intelence-in-hiv-1-infected-patients-132532 https://curecurrent.com/trials/euroneut41-safety-immunogenicity-of-immunisations-with-hiv-vaccine-132533 https://curecurrent.com/trials/safety-immunogenicity-of-immunisations-with-en41-ugr7c-hiv-vaccine-132534 https://curecurrent.com/trials/the-cognaive-study-assessing-changes-in-neurocognitive-function-in-treatment-na-ve-hiv-1-positive-subjects-132535 https://curecurrent.com/trials/observational-non-interventional-study-with-viramune-in-combination-with-truvada-in-hiv-infected-patients-132536 https://curecurrent.com/trials/pharmacology-of-antimalarial-therapy-with-or-without-antiretroviral-therapy-132537 https://curecurrent.com/trials/a-study-to-investigate-the-recovery-excretion-and-pharmacokinetics-of-14c-gsk2248761-administered-as-an-oral-suspension-132538 https://curecurrent.com/trials/evaluating-host-and-viral-factors-among-hiv-infected-former-commercial-blood-donors-in-fuyang-anhui-province-china-132539 https://curecurrent.com/trials/collection-of-blood-samples-from-hiv-infected-people-132540 https://curecurrent.com/trials/impaact-p1073-study-of-iris-for-infants-and-children-initiating-haart-at-int-l-sites-132541 https://curecurrent.com/trials/acipimox-to-improve-hyperlipidemia-and-insulin-sensitivity-associated-with-hiv-132542 https://curecurrent.com/trials/safety-and-antiviral-activity-of-tpv-in-hcv-and-or-hbv-hiv-coinfected-patients-tdm-randomised-pilot-evaluation-132543 https://curecurrent.com/trials/comparison-of-tpv-r-to-drv-r-in-triple-class-experienced-patient-with-resistance-to-1-pi-132544 https://curecurrent.com/trials/rifabutin-based-therapy-for-the-eradication-of-staphylococcus-aureus-colonization-in-hiv-infected-adults-132545 https://curecurrent.com/trials/combination-chemotherapy-and-rituximab-in-treating-patients-with-hiv-associated-stage-i-stage-ii-stage-iii-or-stage-iv-n-132546 https://curecurrent.com/trials/safety-and-acceptability-of-the-prepex-device-for-male-circumcision-in-zambia-132547 https://curecurrent.com/trials/pentoxifylline-and-combination-antiretroviral-therapy-to-improve-blood-vessel-function-in-hiv-infected-people-132548 https://curecurrent.com/trials/pharmacokinetics-and-safety-study-of-tipranavir-in-combination-with-low-dose-ritonavir-in-human-immunodeficiency-virus-h-132549 https://curecurrent.com/trials/positively-smoke-free-on-the-web-psfw-for-smokers-living-with-hiv-132550 https://curecurrent.com/trials/non-enrolment-and-non-adherence-to-hiv-care-in-a-community-based-program-rakai-uganda-132551 https://curecurrent.com/trials/an-exploratory-rectal-safety-study-of-three-tenofovir-gel-formulations-132552 https://curecurrent.com/trials/dcvax-plus-poly-iclc-in-healthy-volunteers-132553 https://curecurrent.com/trials/disulfiram-interactions-with-hiv-medications-clinical-implications-132554 https://curecurrent.com/trials/interaction-of-buprenorphine-with-hiv-medications-and-tuberculosis-medications-132555 https://curecurrent.com/trials/interaction-of-alcohol-and-highly-active-antiretroviral-therapy-haart-in-hiv-aids-and-hiv-aids-with-hepatitis-c-virus-hc-132556 https://curecurrent.com/trials/dose-response-study-of-ibalizumab-monoclonal-antibody-plus-optimized-background-regimen-in-patients-with-hiv-1-132557 https://curecurrent.com/trials/engaging-informal-health-care-providers-on-case-detection-and-treatment-initiation-rates-for-tb-and-hiv-in-rural-malawi-132558 https://curecurrent.com/trials/safety-and-immunogenicity-study-of-three-candidate-hiv-1-vaccines-administered-in-combination-to-healthy-hiv-1-uninfecte-132559 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-efavirenz-in-hiv-infected-children-132560 https://curecurrent.com/trials/a-12-week-study-comparing-pitavastatin-4-mg-vs-pravastatin-40-mg-in-hiv-infected-subjects-132561 https://curecurrent.com/trials/serological-response-to-antipneumococcal-vaccination-and-impact-on-streptococcus-pneumoniae-nasal-carriage-in-hiv-adults-132562 https://curecurrent.com/trials/immunogenicity-of-inactivated-swine-h1n1-vaccine-in-hiv-infected-children-the-miami-cohort-study-132563 https://curecurrent.com/trials/immune-responses-to-pneumococcal-vaccination-among-hiv-infected-subjects-132564 https://curecurrent.com/trials/clinical-trial-of-cns-targeted-haart-cit2-132565 https://curecurrent.com/trials/the-natural-history-and-treatment-of-acute-hepatitis-c-virus-hcv-in-hiv-positive-individuals-132566 https://curecurrent.com/trials/immunosuppression-in-hiv-infected-patients-with-tuberculosis-in-ethiopia-132567 https://curecurrent.com/trials/a-safety-study-to-evaluate-the-antiviral-activity-of-darunavir-in-combination-with-ritonavir-in-hiv-1-infected-children-132568 https://curecurrent.com/trials/differences-in-response-to-the-flu-vaccine-among-adults-with-hiv-and-without-hiv-in-uganda-132569 https://curecurrent.com/trials/quality-of-life-in-children-with-hiv-infection-132570 https://curecurrent.com/trials/hiv-cohort-study-at-johns-hopkins-university-university-of-north-carolina-at-chapel-hill-and-vanderbilt-university-132571 https://curecurrent.com/trials/a-randomized-study-to-assess-the-relative-bioavailability-of-new-formulations-of-gsk1265744-long-acting-parental-lap-in-132572 https://curecurrent.com/trials/grace-a-study-to-compare-the-effectiveness-safety-and-tolerability-of-prezista-darunavir-ritonavir-by-gender-and-race-wh-132573 https://curecurrent.com/trials/effects-of-two-anti-hiv-drug-regimens-on-quality-of-life-and-health-care-use-among-smart-study-participants-132574 https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-effectiveness-of-three-anti-hiv-drug-regimens-in-hiv-infected-patients-who-have-never-132575 https://curecurrent.com/trials/the-effect-of-anti-hiv-therapy-on-fat-metabolism-in-hiv-positive-patients-132576 https://curecurrent.com/trials/effects-of-two-anti-hiv-drug-regimens-on-hiv-transmission-risk-behavior-among-smart-study-participants-132577 https://curecurrent.com/trials/effects-of-anti-hiv-therapy-on-nervous-system-function-132578 https://curecurrent.com/trials/a-study-of-anal-cancer-development-in-hiv-infected-people-132579 https://curecurrent.com/trials/raltegravir-use-as-nonoccupational-postexposure-prophylaxis-npep-in-men-who-have-sex-with-men-132580 https://curecurrent.com/trials/a-study-of-the-long-term-outcomes-of-hiv-positive-patients-132581 https://curecurrent.com/trials/oral-triple-combination-antiviral-drug-therapy-for-treatment-of-influenza-a-in-immunocompromised-subjects-132582 https://curecurrent.com/trials/body-image-in-youth-with-hiv-132583 https://curecurrent.com/trials/comparison-of-efficacy-and-safety-of-infant-peri-exposure-prophylaxis-with-lopinavir-ritonavir-versus-lamivudine-to-prev-132584 https://curecurrent.com/trials/men-who-have-sex-with-men-msm-neurocog-1-2-study-132585 https://curecurrent.com/trials/tmc114-c226-an-early-access-program-to-evaluate-the-long-term-safety-and-tolerability-of-tmc114-combined-with-a-low-dose-132586 https://curecurrent.com/trials/the-effect-of-hyperbilirubinemia-on-cv-disease-neurocog-function-and-renal-function-132587 https://curecurrent.com/trials/discontinuation-of-trimethoprim-sulfamethoxazole-prophylaxis-in-adults-on-antiretroviral-therapy-in-kenya-132588 https://curecurrent.com/trials/safety-and-immunogenicity-study-of-influenza-vaccines-in-hiv-infected-and-hiv-uninfected-pregnant-women-in-western-kenya-132589 https://curecurrent.com/trials/examining-factors-that-may-influence-resistance-to-hiv-1-infection-132590 https://curecurrent.com/trials/study-of-dolutegravir-dtg-on-pk-of-cenicriviroc-cvc-and-cvc-on-pk-of-dtg-on-a-single-dose-of-midazolam-132591 https://curecurrent.com/trials/project-unity-hiv-risk-reduction-and-vaccine-education-interventions-132592 https://curecurrent.com/trials/valacyclovir-vs-acyclovir-as-hsv-2-suppressive-therapy-effect-on-plasma-hiv-1-levels-among-hiv-1-hsv-2-co-infected-perso-132593 https://curecurrent.com/trials/home-assessment-and-initiation-of-antiretroviral-therapy-for-hiv-in-malawi-132594 https://curecurrent.com/trials/verxve-study-on-efficacy-and-safety-of-nevirapine-xr-in-comparison-to-nevirapine-ir-with-truvada-in-naive-hiv-patients-132595 https://curecurrent.com/trials/observational-non-interventional-study-anwendungsbeobachtung-with-aptivus-tipranavir-in-hiv-infected-patients-132596 https://curecurrent.com/trials/europe-africa-research-network-for-evaluation-of-second-line-therapy-132597 https://curecurrent.com/trials/effects-of-motivational-interviewing-on-risky-injecting-practices-among-injecting-drug-users-idus-132598 https://curecurrent.com/trials/tb-iris-nsaid-cox-2-inhibitor-prevention-trial-132599 https://curecurrent.com/trials/tmc207-tidp13-c117-interaction-study-in-human-immunodeficiency-virus-type-1-hiv-1-infected-patients-with-nevirapine-nvp-132600 https://curecurrent.com/trials/efficacy-and-safety-of-two-pharmacologic-strategies-on-neurocognitive-impairment-in-hiv-infection-the-triant-te-study-132601 https://curecurrent.com/trials/clinical-outcomes-of-cryptococcal-meningitis-among-hiv-infected-patients-in-the-era-of-antiretroviral-therapy-132602 https://curecurrent.com/trials/study-of-recovery-of-intestinal-cd4-and-th17-t-cells-in-hiv-infected-individuals-on-short-term-antiretroviral-therapy-132603 https://curecurrent.com/trials/immunization-with-hiv-1-peptides-in-adjuvant-for-treatment-of-patients-with-chronic-hiv-infection-132604 https://curecurrent.com/trials/an-efficacy-and-safety-trial-of-serostim-in-the-maintenance-of-the-treatment-effect-obtained-during-the-study-of-serosti-132605 https://curecurrent.com/trials/safety-and-efficacy-trial-of-serostim-in-the-treatment-of-subjects-with-human-immunodeficiency-virus-associated-adipose-132606 https://curecurrent.com/trials/aripiprazole-treatment-for-methamphetamine-dependence-among-high-risk-individuals-132607 https://curecurrent.com/trials/comparison-of-liquid-kaletra-and-low-dose-kaletra-tablets-132608 https://curecurrent.com/trials/a-post-marketing-surveillance-study-assessing-the-long-term-efficacy-and-safety-of-aptivus-co-administered-with-low-dose-132609 https://curecurrent.com/trials/co-receptor-tropism-determination-of-hiv-1-subtype-a-spread-in-the-russian-federation-using-v3-based-genotyping-tools-132610 https://curecurrent.com/trials/penta15-pharmacokinetic-study-of-once-versus-twice-daily-abacavir-in-hiv-1-infected-children-aged-3-to-36-months-132611 https://curecurrent.com/trials/evaluation-of-alternative-antimalarial-drugs-for-malaria-in-pregnancy-132612 https://curecurrent.com/trials/influence-of-atorvastatin-on-viral-replication-during-antiretroviral-treatment-interruption-132613 https://curecurrent.com/trials/long-term-effects-of-highly-active-anti-retroviral-therapy-on-hiv-infected-children-132614 https://curecurrent.com/trials/effects-of-highly-active-anti-retroviral-therapy-on-cardiovascular-health-in-infants-of-hiv-infected-mothers-132615 https://curecurrent.com/trials/a-study-to-evaluate-safety-and-immunogenicity-of-aeras-402-132616 https://curecurrent.com/trials/a-phase-i-study-to-evaluate-safety-and-immunogenicity-of-aeras-404-administered-in-adults-132617 https://curecurrent.com/trials/fanconi-syndrome-due-to-arvs-in-hiv-infected-persons-132618 https://curecurrent.com/trials/safety-study-of-once-a-day-art-and-opiate-substitute-132619 https://curecurrent.com/trials/project-power-an-hiv-risk-reduction-intervention-for-black-men-who-have-sex-with-men-and-women-bmsm-w-132620 https://curecurrent.com/trials/innate-immunity-in-hiv-positive-patients-co-infected-with-hepatitis-c-virus-hcv-or-hepatitis-b-virus-hbv-132621 https://curecurrent.com/trials/extended-safety-study-of-tenofovir-disoproxil-fumarate-tdf-among-hiv-1-negative-men-132622 https://curecurrent.com/trials/extended-infant-post-exposure-prophylaxis-with-antiretrovirals-to-reduce-postnatal-hiv-transmission-132623 https://curecurrent.com/trials/pms-assessing-the-long-term-efficacy-and-safety-of-nevirapine-therapy-combined-with-other-arv-drugs-in-hiv-1-positive-pa-132624 https://curecurrent.com/trials/rollover-trial-safety-and-tolerability-of-combination-tipranavir-and-ritonavir-use-in-hiv-1-infected-subjects-132625 https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-and-cervicovaginal-lavage-of-combined-oral-contraceptives-and-raltegravir-132626 https://curecurrent.com/trials/familias-unidas-preventing-drug-abuse-and-hiv-in-hispanic-first-offenders-132627 https://curecurrent.com/trials/immunogenicity-of-three-hiv-gtu-multihiv-dna-immunisations-administered-via-intramuscular-intradermal-and-transcutaneous-132628 https://curecurrent.com/trials/combivir-and-maraviroc-in-antiretroviral-naive-subjects-in-russia-132629 https://curecurrent.com/trials/an-evidence-based-smoking-cessation-program-for-persons-living-with-hiv-aids-project-legacy-132630 https://curecurrent.com/trials/evaluating-the-pharmacokinetics-of-400-mg-oral-dose-of-raltegravir-in-hiv-infected-pre-menopausal-women-132631 https://curecurrent.com/trials/the-multimedia-hiv-sti-prevention-for-drug-involved-female-offenders-132632 https://curecurrent.com/trials/hiv-prevention-for-injecting-drug-users-in-kazakhstan-132633 https://curecurrent.com/trials/dendritic-cell-vaccine-in-hiv-1-infection-132634 https://curecurrent.com/trials/does-provision-of-point-of-care-cd4-technology-and-early-knowledge-of-cd4-levels-affect-early-initiation-and-retention-o-132635 https://curecurrent.com/trials/safety-and-effect-of-the-hdac-inhibitor-panobinostat-on-hiv-1-expression-in-patients-on-suppressive-haart-132636 https://curecurrent.com/trials/violence-and-hiv-risk-among-women-132637 https://curecurrent.com/trials/a-phase-i-randomized-placebo-controlled-double-blind-study-to-evaluate-safety-and-immunogenicity-of-aeras-404-administer-132638 https://curecurrent.com/trials/prevention-of-early-mortality-by-presumptive-tuberculosis-tb-treatment-132639 https://curecurrent.com/trials/clinical-study-to-evaluate-the-efficacy-and-safety-of-lopinavir-ritonavir-monotherapy-versus-darunavir-ritonavir-monothe-132640 https://curecurrent.com/trials/early-versus-delayed-pneumococcal-vaccination-in-hiv-132641 https://curecurrent.com/trials/hydroxychloroquine-for-discordant-cd4-responders-on-highly-active-antiretroviral-therapy-haart-132642 https://curecurrent.com/trials/a-study-of-amd11070-in-hiv-infected-patients-carrying-x4-tropic-virus-132643 https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-repeat-dose-administration-of-long-acting-gsk1265-132644 https://curecurrent.com/trials/tmc114-tidp3-c176-a-study-in-healthy-volunteers-investigating-the-bioequivalence-between-two-commercially-available-400-132645 https://curecurrent.com/trials/optimisation-of-primary-hiv1-infection-treatment-anrs-147-optiprim-132646 https://curecurrent.com/trials/study-of-anti-r-huepo-associated-pure-red-cell-aplasia-prca-treatment-132647 https://curecurrent.com/trials/na-ve-hiv-poc-monotherapy-trial-132648 https://curecurrent.com/trials/nevirapine-vs-atazanavir-boosted-with-ritonavir-on-a-background-of-truvada-in-human-immunodeficiency-virus-hiv-infected-132649 https://curecurrent.com/trials/effect-of-carbamazepine-on-dolutegravir-pharmacokinetics-in-healthy-adult-subjects-132650 https://curecurrent.com/trials/effectiveness-of-a-risk-reduction-program-in-preventing-the-transmission-of-hiv-and-sexually-transmitted-diseases-in-afr-132651 https://curecurrent.com/trials/nevirapine-or-atazanavir-ritonavir-given-with-emtricitabine-tenofovir-in-human-immunodeficiency-virus-hiv-1-infected-tre-132652 https://curecurrent.com/trials/a-study-of-different-doses-of-uk-453-061-plus-truvada-compared-to-efavirenz-plus-truvada-in-patients-who-have-not-been-p-132653 https://curecurrent.com/trials/a-case-management-intervention-to-prevent-er-visits-in-hiv-infected-persons-132654 https://curecurrent.com/trials/safety-and-metabolic-study-of-highly-active-antiretroviral-therapy-haart-in-malnourished-children-with-hiv-132655 https://curecurrent.com/trials/study-of-protease-inhibitor-regimen-switch-in-hiv-1-infected-patients-with-undetectable-viral-load-to-prove-the-non-infe-132656 https://curecurrent.com/trials/promoting-male-involvement-to-improve-prevention-of-mother-to-child-transmission-pmtct-uptake-and-reduce-antenatal-infec-132657 https://curecurrent.com/trials/comparison-of-hiv-testing-algorithms-132658 https://curecurrent.com/trials/safety-study-of-mva-smallpox-vaccine-in-hiv-positive-subjects-who-are-vaccinia-naive-132659 https://curecurrent.com/trials/kidney-and-liver-transplantation-in-people-with-hiv-132660 https://curecurrent.com/trials/ipv-in-moderate-to-severe-chronic-malnourished-9-12-month-old-children-in-karachi-132661 https://curecurrent.com/trials/rhiv-a-pilot-study-refractory-or-intolerant-to-highly-active-antiretroviral-therapy-haart-132662 https://curecurrent.com/trials/the-once-a-day-protease-inhibitor-regimens-132663 https://curecurrent.com/trials/a-dose-escalation-study-of-tenofovir-alafenamide-in-treatment-naive-patients-132664 https://curecurrent.com/trials/immunotherapy-with-vacc-c5-with-adjuvant-gm-csf-or-alhydrogel-in-hiv-1-infected-subjects-on-art-132665 https://curecurrent.com/trials/shaping-the-health-of-adolescents-in-zimbabwe-132666 https://curecurrent.com/trials/an-expanded-access-study-of-oral-liquid-efavirenz-in-the-treatment-of-children-with-hiv-infection-canada-132667 https://curecurrent.com/trials/an-expanded-access-study-of-oral-liquid-efavirenz-in-the-treatment-of-children-with-hiv-infection-132668 https://curecurrent.com/trials/effects-of-short-term-growth-hormone-in-hiv-infected-patients-132669 https://curecurrent.com/trials/a-study-of-physical-and-metabolic-abnormalities-in-hiv-infected-and-uninfected-children-and-youth-132670 https://curecurrent.com/trials/hiv-prevention-preparedness-study-in-russia-china-and-india-132671 https://curecurrent.com/trials/improving-treatment-adherence-in-hiv-infected-individuals-132672 https://curecurrent.com/trials/a-study-to-explore-reconstitution-of-immunity-in-patients-with-advanced-hiv-1-infection-132673 https://curecurrent.com/trials/effects-of-switching-efavirenz-to-raltegravir-on-vascular-function-and-bone-markers-in-hiv-infected-patients-132674 https://curecurrent.com/trials/raltegravir-switch-study-effects-on-endothelial-recovery-132675 https://curecurrent.com/trials/s-t-a-r-s-sistas-talking-about-real-solutions-132676 https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-study-of-th9507-a-growth-hormone-releasing-factor-analog-in-hiv-positive-patients-132677 https://curecurrent.com/trials/evaluating-rewards-based-adherence-and-electronic-medication-monitoring-in-hiv-positive-adolescents-132678 https://curecurrent.com/trials/effectiveness-of-hiv-risk-reduction-program-among-african-american-men-132679 https://curecurrent.com/trials/effectiveness-of-community-level-behavioral-and-biomedical-interventions-for-reducing-hiv-stis-in-men-in-peru-132680 https://curecurrent.com/trials/effectiveness-of-hiv-sexually-transmitted-infection-training-for-physicians-in-china-132681 https://curecurrent.com/trials/prospective-evaluation-of-etravirine-for-hiv-infected-patients-in-need-of-lipid-lowering-drugs-132682 https://curecurrent.com/trials/community-mobilization-mobile-testing-same-day-results-and-post-test-support-for-hiv-in-sub-saharan-africa-and-thailand-132683 https://curecurrent.com/trials/hiv-counseling-and-testing-and-linkage-to-care-in-uganda-132684 https://curecurrent.com/trials/pharmacokinetic-and-pharmacodynamic-study-of-tenofovir-1-gel-132685 https://curecurrent.com/trials/case-management-alternatives-for-african-american-women-at-high-risk-for-hiv-132686 https://curecurrent.com/trials/gud-clinical-and-virologic-response-to-acyclovir-in-hiv-negative-african-women-132687 https://curecurrent.com/trials/efficacy-of-ptx-ifn-alpha-rbv-on-hepatitis-c-virus-coinfected-hiv-patients-132688 https://curecurrent.com/trials/immunogenicity-and-safety-of-trivalent-influenza-vaccine-in-non-pregnant-hiv-infected-women-132689 https://curecurrent.com/trials/novel-therapy-for-glucose-intolerance-in-hiv-disease-132690 https://curecurrent.com/trials/cognitive-stimulation-program-in-aids-132691 https://curecurrent.com/trials/promoting-uptake-and-retention-of-option-b-in-malawi-132692 https://curecurrent.com/trials/effect-of-dha-on-lipid-and-carbohydrate-metabolism-alterations-and-body-fat-distribution-in-hiv-patients-under-haart-132693 https://curecurrent.com/trials/chloroquine-as-a-modulator-of-t-cell-immune-activation-132694 https://curecurrent.com/trials/integrating-family-planning-services-into-hiv-care-and-treatment-in-nyanza-province-kenya-132695 https://curecurrent.com/trials/antiretroviral-therapy-and-extreme-weight-132696 https://curecurrent.com/trials/examining-the-incidence-of-oral-human-papillomavirus-hpv-shedding-and-oral-warts-after-beginning-haart-in-hiv-infected-a-132697 https://curecurrent.com/trials/long-term-data-collection-from-participants-in-adult-aids-clinical-trials-132698 https://curecurrent.com/trials/associations-outcomes-and-genomics-of-gb-virus-c-hepatitis-c-virus-and-human-immunodeficiency-virus-infection-132699 https://curecurrent.com/trials/phase-iia-dose-ranging-study-of-gsk1349572-in-hiv-1-infected-adults-132700 https://curecurrent.com/trials/safety-and-efficacy-study-of-twhf-in-hiv-patients-with-poor-immune-responses-132701 https://curecurrent.com/trials/when-to-start-anti-hiv-drugs-in-children-infected-with-hiv-the-predict-study-132702 https://curecurrent.com/trials/gene-therapy-chemotherapy-and-peripheral-stem-cell-transplantation-in-treating-patients-with-hiv-related-non-hodgkin-s-l-132703 https://curecurrent.com/trials/group-psychotherapy-for-people-with-hiv-132704 https://curecurrent.com/trials/a-study-of-the-once-daily-combination-of-etravirine-and-darunavir-ritonavir-as-dual-therapy-in-early-treatment-experienc-132705 https://curecurrent.com/trials/safety-and-immunogenicity-study-of-a-dna-priming-and-mva-boosting-strategy-of-hiv-vaccine-132706 https://curecurrent.com/trials/group-therapies-for-reducing-hiv-risk-behavior-in-women-who-have-survived-childhood-sexual-abuse-132707 https://curecurrent.com/trials/kaletra-sex-gender-pharmacokinetics-pk-study-132708 https://curecurrent.com/trials/safety-of-acidform-lubricant-in-hiv-uninfected-women-132709 https://curecurrent.com/trials/subclinical-atherosclerosis-in-hiv-infected-patients-132710 https://curecurrent.com/trials/a-tailored-interactive-website-for-promoting-condom-use-among-young-adults-132711 https://curecurrent.com/trials/th9507-in-patients-with-hiv-associated-lipodystrophy-132712 https://curecurrent.com/trials/observational-study-of-male-circumcision-using-prepex-device-132713 https://curecurrent.com/trials/cdc-hiv-testing-guidelines-unresolved-ethical-concerns-132714 https://curecurrent.com/trials/an-immunologic-study-of-treatment-naive-hiv-patients-starting-a-darunavir-ritonavir-or-efavirenz-based-haart-132715 https://curecurrent.com/trials/comparison-of-the-qt-qtc-interval-between-an-outpatient-hiv-infected-population-on-antiretroviral-therapy-and-two-large-132716 https://curecurrent.com/trials/hiv-risk-reduction-behavioral-intervention-for-commercial-sex-workers-in-yerevan-armenia-132717 https://curecurrent.com/trials/paradoxical-tuberculosis-immune-reconstitution-inflammatory-syndrome-tb-iris-treatment-trial-132718 https://curecurrent.com/trials/role-of-positive-affect-in-adjustment-to-hiv-132719 https://curecurrent.com/trials/utilization-of-hiv-drug-resistance-testing-in-treatment-experienced-patients-utilize-study-132720 https://curecurrent.com/trials/studies-of-influenza-vaccine-and-tetanus-pneumococcal-vaccine-in-hiv-infected-patients-receiving-interleukin-2-132721 https://curecurrent.com/trials/hiv-in-specific-parts-of-the-body-of-patients-who-are-changing-or-starting-potent-anti-hiv-drugs-132722 https://curecurrent.com/trials/social-and-economic-outcomes-of-hiv-aids-care-and-treatment-in-hiv-infected-south-african-adults-132723 https://curecurrent.com/trials/study-of-provider-computer-alerts-designed-to-improve-delivery-of-hiv-care-132724 https://curecurrent.com/trials/trial-embedded-in-an-electronic-personal-medical-health-records-132725 https://curecurrent.com/trials/adherence-improvement-measure-aim-system-132726 https://curecurrent.com/trials/the-effects-of-combination-anti-hiv-medication-on-human-papillomavirus-hpv-in-hiv-infected-women-132727 https://curecurrent.com/trials/controlling-acute-or-early-hiv-infection-with-antiretroviral-drugs-without-a-candidate-vaccine-as-reported-previously-th-132728 https://curecurrent.com/trials/a-simplification-study-of-unboosted-reyataz-with-epzicom-assure-132729 https://curecurrent.com/trials/acute-hiv-infection-observational-study-132730 https://curecurrent.com/trials/horizons-hiv-intervention-132731 https://curecurrent.com/trials/hiv-prevention-for-african-american-teens-132732 https://curecurrent.com/trials/identifying-genes-that-predict-risk-of-developing-cervical-intraepithelial-neoplasia-or-invasive-cervical-cancer-132733 https://curecurrent.com/trials/imara-adapting-sihle-for-detained-african-american-adolescent-females-132734 https://curecurrent.com/trials/modified-directly-observed-antiretroviral-therapy-132735 https://curecurrent.com/trials/antidepressant-medication-plus-directly-observed-therapy-for-improving-adherence-to-antiretroviral-therapy-132736 https://curecurrent.com/trials/computerized-hiv-sexually-transmitted-disease-std-prevention-program-132737 https://curecurrent.com/trials/phase-ii-study-on-the-antiviral-activity-and-safety-of-bilr-355-bs-in-hiv-1-infected-nnrti-treated-patients-132738 https://curecurrent.com/trials/open-label-study-of-nvp-cbv-treatment-in-women-who-have-received-sdnvp-for-the-pmtct-of-hiv-132739 https://curecurrent.com/trials/immune-response-to-hepatitis-c-virus-132740 https://curecurrent.com/trials/pharmacokinetic-pk-study-of-twice-daily-vs-once-daily-lamivudine-3tc-and-abacavir-abc-as-part-of-combination-antiretrovi-132741 https://curecurrent.com/trials/a-pharmacokinetic-pk-study-of-a-combination-of-indinavir-ritonavir-and-amprenavir-132742 https://curecurrent.com/trials/a-study-to-compare-three-different-formulations-of-tenofovir-1-gel-when-administered-rectally-132743 https://curecurrent.com/trials/study-of-darunavir-r-tenofovir-emtricitabine-vs-darunavir-r-raltegravir-in-hiv-infected-antiretroviral-na-ve-subjects-132744 https://curecurrent.com/trials/safety-study-of-tipranavir-co-administered-with-low-dose-ritonavir-tpv-r-in-patients-with-advanced-hiv-1-infection-and-l-132745 https://curecurrent.com/trials/a-study-of-single-dose-nevirapine-nvp-combined-with-combivir-for-the-prevention-of-mother-to-child-transmission-pmtct-tr-132746 https://curecurrent.com/trials/effectiveness-of-a-community-level-hiv-std-prevention-intervention-in-promoting-safer-sexual-behaviors-in-high-risk-popu-132747 https://curecurrent.com/trials/an-study-to-investigate-the-recovery-excretion-and-pharmacokinetics-of-14c-gsk1265744-administered-as-a-single-oral-dose-132748 https://curecurrent.com/trials/a-randomised-trial-to-evaluate-the-antiviral-efficacy-and-safety-of-treatment-with-500-mg-tipranavir-tpv-plus-100-mg-or-132749 https://curecurrent.com/trials/quality-of-life-and-changes-in-metabolism-of-lipids-and-glucose-after-switching-to-a-nevirapine-based-regimen-in-hiv-pat-132750 https://curecurrent.com/trials/trial-to-evaluate-steady-state-pharmacokinetic-parameters-efficacy-and-safety-of-nevirapine-in-antiretroviral-drug-na-ve-132751 https://curecurrent.com/trials/pharmacokinetic-study-of-interaction-between-nevirapine-and-methadone-in-hiv-1-infected-opioid-dependent-adults-132752 https://curecurrent.com/trials/the-effect-of-intermittent-rifampicin-on-raltegravir-132753 https://curecurrent.com/trials/biomarkers-of-protocol-compliance-and-product-adherence-132754 https://curecurrent.com/trials/a-phase-2-study-of-pf-00232798-in-hiv-positive-patients-132755 https://curecurrent.com/trials/study-to-evaluate-safety-and-immunogenicity-of-vpm1002-in-comparison-with-bcg-in-newborn-infants-in-south-africa-132756 https://curecurrent.com/trials/rwanda-selenium-supplementation-clinical-trial-132757 https://curecurrent.com/trials/pharmacokinetics-of-the-tablet-formulation-of-lopinavir-r-as-standard-and-increased-dosage-during-pregnancy-132758 https://curecurrent.com/trials/randomized-control-trial-copper-intrauterine-device-and-depo-medroxyprogesterone-acetate-dmpa-of-hiv-women-in-malawi-132759 https://curecurrent.com/trials/establishing-effectiveness-of-daily-co-trimoxazole-prophylaxis-for-prevention-of-malaria-in-pregnancy-132760 https://curecurrent.com/trials/growth-hormone-in-the-treatment-of-hiv-associated-wasting-132761 https://curecurrent.com/trials/a-study-in-asymptomatic-hiv-infected-patients-to-investigate-pharmacodynamics-pharmacokinetics-safety-and-toleration-of-132762 https://curecurrent.com/trials/interactions-between-hiv-and-malaria-in-african-children-132763 https://curecurrent.com/trials/safety-and-efficacy-of-telaprevir-in-combination-with-peginterferon-alfa-2a-and-ribavirin-in-subjects-co-infected-with-h-132764 https://curecurrent.com/trials/trial-of-maraviroc-uk-427-857-in-combination-with-zidovudine-lamivudine-versus-efavirenz-in-combination-with-zidovudine-132765 https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-the-prepextm-device-for-rapid-scale-up-of-adult-mc-programs-in-zimbabwe-132766 https://curecurrent.com/trials/blood-levels-of-abacavir-in-hiv-infected-adolescents-132767 https://curecurrent.com/trials/safety-and-efficacy-of-the-prepex-device-circumcision-when-performed-by-nurses-132768 https://curecurrent.com/trials/comparing-the-prepex-device-to-surgical-mc-for-rapid-scale-up-of-mc-in-resource-limited-setting-132769 https://curecurrent.com/trials/long-term-effects-of-hiv-exposure-and-infection-in-children-132770 https://curecurrent.com/trials/a-study-on-the-effect-of-high-calorie-infant-formula-on-growth-and-nutrition-in-hiv-infected-infants-132771 https://curecurrent.com/trials/anti-hiv-drug-regimens-with-or-without-protease-inhibitors-and-drug-level-monitoring-in-hiv-infected-adolescents-132772 https://curecurrent.com/trials/the-effects-of-anti-hiv-therapy-on-the-immune-systems-of-children-and-young-adults-infected-with-hiv-132773 https://curecurrent.com/trials/a-study-to-collect-information-about-hiv-positive-pregnant-women-and-their-babies-132774 https://curecurrent.com/trials/stopping-and-restarting-anti-hiv-drugs-in-children-and-adolescents-with-low-blood-levels-of-hiv-132775 https://curecurrent.com/trials/zidovudine-and-lamivudine-given-once-versus-twice-daily-132776 https://curecurrent.com/trials/a-comparison-of-two-caloric-supplements-in-the-prevention-of-weight-loss-in-patients-with-aids-who-take-daily-multivitam-132777 https://curecurrent.com/trials/two-stage-tuberculin-ppd-skin-testing-in-individuals-with-human-immunodeficiency-virus-hiv-infection-132778 https://curecurrent.com/trials/the-safety-and-effectiveness-of-adefovir-dipivoxil-in-the-treatment-of-hiv-infected-patients-132779 https://curecurrent.com/trials/a-study-of-psychosocial-and-behavioral-determinants-of-differential-rates-of-participant-compliance-in-cpcra-protocols-132780 https://curecurrent.com/trials/a-study-of-two-adherence-plans-to-help-hiv-positive-patients-take-their-medications-correctly-132781 https://curecurrent.com/trials/a-registry-of-tuberculosis-cases-in-the-cpcra-132782 https://curecurrent.com/trials/a-comparison-of-two-anti-hiv-treatment-plans-132783 https://curecurrent.com/trials/a-pilot-study-of-the-short-term-effects-of-antiretroviral-management-based-on-plasma-genotypic-antiretroviral-resistance-132784 https://curecurrent.com/trials/tmc125-tidp2-c238-an-exploratory-pharmacokinetics-safety-and-anti-hiv-activity-study-of-etravirine-etr-when-given-with-b-132785 https://curecurrent.com/trials/maternal-determinants-of-hiv-exposed-and-hiv-unexposed-fetal-growth-birth-outcomes-and-early-infant-growth-132786 https://curecurrent.com/trials/effectiveness-of-acyclovir-in-suppressing-hiv-viral-load-in-women-coinfected-with-hiv-and-herpes-simplex-virus-type-2-hs-132787 https://curecurrent.com/trials/vertical-transmission-study-132788 https://curecurrent.com/trials/estimating-the-incidence-of-hiv-infection-among-men-who-have-sex-with-men-in-peru-and-ecuador-132789 https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-hodgkin-s-disease-and-hiv-infection-132790 https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-hiv-related-non-hodgkin-s-lymphoma-132791 https://curecurrent.com/trials/chemotherapy-and-radiation-therapy-in-treating-patients-with-hiv-related-primary-central-nervous-system-lymphoma-132792 https://curecurrent.com/trials/combination-chemotherapy-plus-filgrastim-in-treating-patients-with-hiv-related-non-hodgkin-s-lymphoma-132793 https://curecurrent.com/trials/rituximab-plus-combination-chemotherapy-in-treating-patients-with-hiv-related-non-hodgkin-s-lymphoma-132794 https://curecurrent.com/trials/antiviral-therapy-in-treating-patients-with-slowly-progressing-hiv-related-kaposi-s-sarcoma-132795 https://curecurrent.com/trials/the-neurocognitive-sub-study-of-encore1-132796 https://curecurrent.com/trials/comparison-of-treatment-simplification-by-lpv-r-vs-current-treatment-continuation-in-hiv-infected-patients-132797 https://curecurrent.com/trials/vitamin-d-dose-finding-study-132798 https://curecurrent.com/trials/comparisons-of-serologic-response-of-early-syphilis-132799 https://curecurrent.com/trials/motivating-hiv-women-risk-reduction-and-art-adherence-132800 https://curecurrent.com/trials/efficacy-and-safety-study-of-miconazole-lauriad-to-treat-oropharyngeal-candidiasis-in-hiv-patients-132801 https://curecurrent.com/trials/prevention-of-lipoatrophy-in-patients-treated-with-lopinavir-ritonavir-in-monotherapy-versus-zdv-3tc-abc-132802 https://curecurrent.com/trials/a-feasibility-study-of-co-administering-combination-antiretroviral-therapy-cart-and-r-epoch-chemotherapy-for-the-managem-132803 https://curecurrent.com/trials/long-term-atazanavir-experience-in-a-high-hiv-caseload-primary-care-practice-in-sydney-australia-132804 https://curecurrent.com/trials/maraviroc-immune-recovery-study-132805 https://curecurrent.com/trials/safety-and-immune-response-assessment-study-of-killed-whole-hiv-1-vaccine-sav001-h-in-chronic-hiv-1-infected-patients-132806 https://curecurrent.com/trials/intervention-to-retain-hiv-positive-patients-in-medical-care-132807 https://curecurrent.com/trials/safety-of-and-immune-response-to-prime-boost-vaccine-regimens-in-healthy-hiv-1-uninfected-ad5-seronegative-adults-132808 https://curecurrent.com/trials/efavirenz-and-lamivudine-zidovudine-for-treatment-naive-hiv-infected-adults-in-senegal-132809 https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-a-protease-inhibitor-and-of-interleukin-2-il-2-in-the-treatment-of-early-hiv-infection-132810 https://curecurrent.com/trials/neighborhoods-networks-depression-and-hiv-risk-132811 https://curecurrent.com/trials/study-on-long-term-outcomes-of-atazanavir-in-antiretroviral-na-ve-human-immunodeficiency-virus-hiv-patients-in-real-life-132812 https://curecurrent.com/trials/evaluation-of-an-intervention-on-adherence-to-highly-active-antiretroviral-therapy-haart-in-hiv-infected-adults-132813 https://curecurrent.com/trials/tmc114-tidp3-c182-a-study-to-compare-the-oral-bioavailability-of-a-800-mg-prototype-tablet-formulation-of-darunivar-drv-132814 https://curecurrent.com/trials/a-phase-i-open-label-trial-to-explore-the-pharmacokinetics-safety-and-tolerability-of-tmc278-rilpivirine-25-mg-once-dail-132815 https://curecurrent.com/trials/a-randomized-dose-ranging-study-of-alferon-ldo-in-asymptomatic-hiv-subjects-132816 https://curecurrent.com/trials/novel-interventions-in-hiv-1-infection-132817 https://curecurrent.com/trials/novel-measures-and-theory-of-pediatric-antiretroviral-therapy-adherence-in-uganda-132818 https://curecurrent.com/trials/safety-and-immunogenicity-study-of-hiv-mag-vaccine-il-12-and-ad35-grin-env-in-hiv-uninfected-volunteers-132819 https://curecurrent.com/trials/home-based-versus-partner-friendly-clinic-testing-to-enhance-male-partner-hiv-1-testing-during-pregnancy-132820 https://curecurrent.com/trials/nevirapine-vs-ritonavir-boosted-lopinavir-in-art-naive-hiv-infected-adults-in-a-resource-limited-setting-132821 https://curecurrent.com/trials/russian-labor-migrant-hiv-prevention-trial-132822 https://curecurrent.com/trials/hsv-2-suppression-to-reduce-hiv-1-levels-in-hiv-1-co-infected-persons-132823 https://curecurrent.com/trials/hsv-2-suppression-to-reduce-hiv-1-levels-in-hiv-1-hsv-2-co-infected-men-132824 https://curecurrent.com/trials/effectiveness-of-a-telephone-intervention-program-in-improving-depression-coping-and-family-functioning-in-hiv-infected-132825 https://curecurrent.com/trials/cognitive-behavioral-therapy-combined-with-antidepressants-to-reduce-hiv-risk-and-drug-relapse-among-depressed-intraveno-132826 https://curecurrent.com/trials/antidepressant-medication-for-reducing-hiv-risk-behavior-in-depressed-intravenous-drug-users-132827 https://curecurrent.com/trials/infant-male-circumcision-in-gaborone-botswana-and-surrounding-areas-feasibility-safety-and-acceptability-132828 https://curecurrent.com/trials/using-implementation-intentions-to-increase-safe-sex-practices-in-msm-132829 https://curecurrent.com/trials/immune-response-to-bivalent-and-tetravalent-human-papillomavirus-vaccine-in-hiv-infected-adults-132830 https://curecurrent.com/trials/thalidomide-in-treating-patients-with-hiv-associated-kaposi-s-sarcoma-132831 https://curecurrent.com/trials/safety-study-of-the-prepex-device-for-non-surgical-adult-male-circumcision-during-phased-in-national-implementation-in-a-132832 https://curecurrent.com/trials/assessment-of-the-effectiveness-of-new-clinical-guidelines-for-differential-diagnosis-and-management-of-common-hiv-aids-132833 https://curecurrent.com/trials/raltegravir-isentress-mk-0518-and-hiv-1-infected-cd4-cells-during-acute-early-hiv-1-132834 https://curecurrent.com/trials/hiv-1-peptide-immunisation-of-individuals-in-west-africa-to-prevent-disease-132835 https://curecurrent.com/trials/metabolic-and-psychological-changes-associated-with-menopause-among-women-with-hiv-132836 https://curecurrent.com/trials/increasing-viral-testing-in-the-emergency-department-132837 https://curecurrent.com/trials/safety-and-efficacy-study-of-serostim-human-immunodeficiency-virus-associated-adipose-redistribution-syndrome-132838 https://curecurrent.com/trials/pre-hiv-test-counseling-intervention-to-reduce-hiv-infection-risk-behavior-in-men-who-are-not-hiv-infected-132839 https://curecurrent.com/trials/safety-and-efficacy-of-an-antibody-to-ccr5-in-individuals-with-hiv-who-are-not-currently-on-antiretroviral-therapy-132840 https://curecurrent.com/trials/study-on-interleukin-7-cyt107-in-hiv-patients-132841 https://curecurrent.com/trials/case-control-viramune-nevirapine-toxicogenomics-study-132842 https://curecurrent.com/trials/using-multimedia-technologies-to-disseminate-an-hiv-prevention-132843 https://curecurrent.com/trials/enfuvirtide-current-protease-inhibitor-switch-to-prezista-darunavir-ritonavir-tmc125-in-hiv-patients-with-enfuvirtide-si-132844 https://curecurrent.com/trials/reasons-for-non-treatment-of-hepatitis-c-in-hcv-mono-infected-patients-versus-hcv-hiv-co-infected-patients-in-a-universi-132845 https://curecurrent.com/trials/the-treatment-of-insomnia-in-patients-with-hiv-disease-132846 https://curecurrent.com/trials/evaluation-of-the-impact-of-mobile-phone-messages-on-art-and-pmtct-adherence-in-mozambique-132847 https://curecurrent.com/trials/virologic-and-immunologic-activity-of-continued-lamivudine-3tc-vs-delavirdine-dlv-in-combination-with-indinavir-idv-and-132848 https://curecurrent.com/trials/a-study-to-evaluate-high-protein-supplementation-in-hiv-positive-patients-with-stable-weight-loss-132849 https://curecurrent.com/trials/effects-of-treatment-changes-on-fat-wasting-in-the-arms-and-legs-of-hiv-patients-132850 https://curecurrent.com/trials/effects-of-changing-hiv-therapy-at-lower-versus-higher-viral-loads-132851 https://curecurrent.com/trials/effect-of-anti-hiv-therapy-haart-on-hiv-levels-in-the-lungs-and-on-lung-cell-inflammation-in-hiv-infected-patients-132852 https://curecurrent.com/trials/blood-vessel-function-in-hiv-infected-patients-taking-anti-hiv-drugs-132853 https://curecurrent.com/trials/simplified-drug-regimens-for-hiv-patients-in-actg-388-or-patients-who-responded-to-a-first-potent-combination-regimen-132854 https://curecurrent.com/trials/nerve-damage-in-patients-with-hiv-infection-who-have-been-treated-with-anti-hiv-drugs-132855 https://curecurrent.com/trials/preliminary-study-of-safety-and-efficacy-of-policosanol-132856 https://curecurrent.com/trials/pharmacokinetics-of-tenofovir-and-tenofovir-diphosphate-emtricitabine-and-emtricitabine-triphosphate-and-rilpivirine-onc-132857 https://curecurrent.com/trials/improving-hiv-prevention-skills-in-people-with-serious-mental-illnesses-132858 https://curecurrent.com/trials/randomized-study-on-multiple-cycles-of-interleukin-7-in-hiv-patients-immune-non-responders-132859 https://curecurrent.com/trials/probiotics-in-the-management-of-necrotizing-enterocolitis-in-hiv-exposed-premature-infants-132860 https://curecurrent.com/trials/metformin-and-rosiglitazone-alone-or-in-combination-in-hiv-infected-patients-with-insulin-and-fat-abnormalities-132861 https://curecurrent.com/trials/the-prevalence-of-hiv-drug-resistance-and-transmission-risk-in-opioid-agonist-treatment-132862 https://curecurrent.com/trials/non-alcoholic-fatty-liver-disease-nafld-in-hiv-the-role-of-nutritional-interventions-132863 https://curecurrent.com/trials/to-determine-if-chromium-nicotinate-supplementation-will-improve-insulin-resistance-in-hiv-patients-with-metabolic-abnor-132864 https://curecurrent.com/trials/acceptability-of-depo-subq-in-uniject-132865 https://curecurrent.com/trials/efficacy-and-safety-of-2-raltegravir-doses-in-naive-hiv-1-infected-patients-receiving-rifampin-for-active-tuberculosis-132866 https://curecurrent.com/trials/pharmacokinetics-of-rifabutin-combined-with-antiretroviral-therapy-in-patients-with-tb-hiv-co-infection-in-vietnam-132867 https://curecurrent.com/trials/evaluation-of-the-extension-at-community-level-of-safe-male-circumcision-anrs-12126-orange-farm-2-132868 https://curecurrent.com/trials/sustainable-hiv-risk-reduction-strategies-for-cj-systems-132869 https://curecurrent.com/trials/nutritional-status-among-na-ve-hiv-infected-patients-and-hiv-infected-patients-receiving-highly-active-antiretroviral-th-132870 https://curecurrent.com/trials/scope-strategies-to-combine-prep-with-prevention-efforts-132871 https://curecurrent.com/trials/a-prospective-observational-study-of-the-clinical-performance-of-femplant-in-pakistan-132872 https://curecurrent.com/trials/a-study-of-the-drug-interactions-between-a-hormonal-emergency-contraception-and-an-hiv-medication-132873 https://curecurrent.com/trials/darunavir-levels-virological-efficacy-proviral-adn-and-resistances-in-patients-on-darunavir-ritonavir-monotherapy-132874 https://curecurrent.com/trials/a-proof-of-concept-study-to-evaluate-the-antiviral-activity-safety-and-pharmacokinetics-of-the-ccr5-antagonist-tbr-652-i-132875 https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-cenicriviroc-cvc-in-combination-with-truvada-or-sustiva-plus-truvada-in-hiv-1-infect-132876 https://curecurrent.com/trials/information-about-hiv-transmission-and-circumcision-on-subsequent-sexual-behavior-and-the-demand-for-circumcision-132877 https://curecurrent.com/trials/hiv-testing-womens-attitudes-on-hiv-vaccine-trials-132878 https://curecurrent.com/trials/potential-for-drug-drug-interactions-between-boceprevir-and-etravirine-in-hiv-hepatitis-c-virus-negative-volunteers-132879 https://curecurrent.com/trials/enhancing-oral-health-care-use-by-hiv-positive-individuals-132880 https://curecurrent.com/trials/a-phase-2-study-to-evaluate-pharmacokinetics-safety-and-efficacy-of-tmc114-ritonavir-rtv-in-human-immunodeficiency-virus-132881 https://curecurrent.com/trials/raltegravir-augmentation-on-persistent-central-nervous-system-cns-immunoactivation-in-treated-hiv-1-patients-132882 https://curecurrent.com/trials/gsk1349572-exposure-in-blood-seminal-fluid-and-rectal-fluid-and-tissue-in-healthy-male-subjects-132883 https://curecurrent.com/trials/a-study-in-underrepresented-patient-population-or-regimen-tolerability-support-132884 https://curecurrent.com/trials/a-prospective-observational-study-of-the-performance-of-zarin-in-kenya-132885 https://curecurrent.com/trials/a-peer-oriented-hiv-prevention-outreach-program-for-individuals-at-high-risk-for-hiv-and-other-stis-132886 https://curecurrent.com/trials/efficacy-and-safety-of-tdf-3tc-efv-in-adults-with-hiv-hbv-coinfection-132887 https://curecurrent.com/trials/a-study-to-compare-brachial-artery-reactivity-and-cardiovascular-risk-of-a-treatment-simplification-by-darunavir-ritonav-132888 https://curecurrent.com/trials/assisting-hiv-infected-mothers-in-disclosing-their-serostatus-to-their-children-132889 https://curecurrent.com/trials/tmc114-c211-trial-of-an-investigational-protease-inhibitor-tmc114-with-ritonavir-tmc114-r-in-hiv-1-infected-patients-who-132890 https://curecurrent.com/trials/study-of-treatment-of-antiretroviral-naive-hiv-1-infected-patients-comparing-tenofovir-disoproxil-fumarate-administered-132891 https://curecurrent.com/trials/pilot-trial-of-novel-circumcision-device-132892 https://curecurrent.com/trials/cognitive-behavioral-therapy-to-help-hiv-infected-adults-with-depression-to-adhere-to-antiretroviral-therapy-132893 https://curecurrent.com/trials/antiviral-therapy-in-treating-patients-with-kaposi-s-sarcoma-with-or-without-hiv-infection-132894 https://curecurrent.com/trials/a-study-with-tmc125-in-human-immunodeficiency-virus-hiv-type-1-infected-patients-who-were-treated-with-tmc125-arm-in-a-s-132895 https://curecurrent.com/trials/safety-and-immunogenicity-of-recombinant-hiv-vaccines-for-hiv-aids-132896 https://curecurrent.com/trials/the-switch-study-the-role-of-lamivudine-emtricitabine-3tc-ftc-in-antiretroviral-regimens-132897 https://curecurrent.com/trials/therapy-targeting-depression-and-hiv-treatment-adherence-the-triad-study-132898 https://curecurrent.com/trials/adherence-intervention-for-people-with-low-literacy-132899 https://curecurrent.com/trials/hsv-oral-reactivation-in-children-132900 https://curecurrent.com/trials/interaction-between-etravirine-or-darunavir-ritonavir-and-artemether-lumefantrine-132901 https://curecurrent.com/trials/therapeutic-intensification-plus-immunomodulation-in-hiv-infected-patients-132902 https://curecurrent.com/trials/diagnosis-and-treatment-of-co-infection-with-human-immunodeficiency-virus-latent-tuberculosis-infection-hiv-tbl-132903 https://curecurrent.com/trials/a-study-to-determine-the-antiviral-activity-of-tmc310911-when-administered-with-ritonavir-in-treatment-naive-human-immun-132904 https://curecurrent.com/trials/rosuvastatin-to-decrease-residual-immune-activation-in-hiv-infection-132905 https://curecurrent.com/trials/trial-of-methadone-maintenance-versus-methadone-detox-in-jail-132906 https://curecurrent.com/trials/safety-immunogenicity-of-13vpnc-in-hiv-infected-subjects-aged-18-or-older-who-were-previously-immunized-with-23vps-132907 https://curecurrent.com/trials/taste-assessment-study-of-2-atazanavir-powder-formulations-in-healthy-subjects-132908 https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-memantine-in-combination-with-anti-hiv-drugs-to-treat-aids-dementia-complex-adc-132909 https://curecurrent.com/trials/hiv-prevention-program-for-patients-receiving-care-at-a-sexually-transmitted-diseases-clinic-132910 https://curecurrent.com/trials/pharmacokinetic-interactions-between-antiretroviral-agents-and-antimalarial-drug-combinations-132911 https://curecurrent.com/trials/drug-interaction-study-between-antimalarial-and-anti-hiv-medications-132912 https://curecurrent.com/trials/immunogenicity-safety-and-tolerability-of-mf59-adjuvanted-versus-non-adjuvanted-influenza-vaccines-in-patients-with-hiv-132913 https://curecurrent.com/trials/halofuginone-hydrobromide-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-132914 https://curecurrent.com/trials/an-innovative-hiv-prevention-intervention-using-social-networking-technology-132915 https://curecurrent.com/trials/risk-reduction-intervention-for-vulnerable-young-adult-males-132916 https://curecurrent.com/trials/intervention-targeting-medication-adherence-and-methamphetamine-use-in-hiv-positive-men-ace-132917 https://curecurrent.com/trials/factors-affecting-adherence-to-anti-hiv-drug-regimens-in-children-and-adolescents-132918 https://curecurrent.com/trials/emd-121974-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-132919 https://curecurrent.com/trials/rapid-hiv-tests-for-women-late-in-pregnancy-and-during-labor-132920 https://curecurrent.com/trials/feasibility-of-a-hepatitis-c-virus-hcv-decision-making-intervention-among-hiv-infected-adults-132921 https://curecurrent.com/trials/umbilical-cord-mesenchymal-stem-cells-for-immune-reconstitution-in-hiv-infected-patients-132922 https://curecurrent.com/trials/a-trial-examining-the-efficacy-of-escitalopram-oxalate-upon-depressive-symptoms-and-fatigue-in-hiv-seropositive-women-132923 https://curecurrent.com/trials/entecavir-intensification-for-persistent-hbv-viremia-in-hiv-hbv-infection-132924 https://curecurrent.com/trials/impact-of-a-computer-assisted-sbirt-program-in-an-hiv-care-setting-132925 https://curecurrent.com/trials/moxifloxacin-as-part-of-a-multi-drug-regimen-for-tuberculosis-132926 https://curecurrent.com/trials/antiretroviral-therapy-for-advanced-hiv-disease-in-south-africa-132927 https://curecurrent.com/trials/observational-study-of-blood-treated-with-cytolin-132928 https://curecurrent.com/trials/a-single-dose-escalation-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-intramuscular-and-subcutan-132929 https://curecurrent.com/trials/a-school-based-hiv-std-prevention-program-to-reduce-risky-sexual-behaviors-among-adolescents-in-liberia-132930 https://curecurrent.com/trials/prevention-of-milk-borne-transmission-of-hiv-1c-in-botswana-132931 https://curecurrent.com/trials/pilot-study-to-assess-gut-mucosal-b-cells-in-individuals-with-hcv-and-hiv-132932 https://curecurrent.com/trials/hiv-diagnosis-in-hospitalized-malawian-infants-132933 https://curecurrent.com/trials/a-randomized-prospective-study-of-the-efficacy-safety-and-tolerability-of-two-doses-of-gw433908ritonavir-given-with-abac-132934 https://curecurrent.com/trials/maintenance-boosted-lopinavir-monotherapy-following-salvage-protease-inhibitor-pi-based-regimen-in-hiv-with-non-nucleosi-132935 https://curecurrent.com/trials/the-intensive-pharmacokinetics-sub-study-of-encore1-encore1-pk-132936 https://curecurrent.com/trials/the-efavirenz-efv-central-nervous-system-exposure-sub-study-of-encore1-132937 https://curecurrent.com/trials/trial-of-impact-of-crime-group-intervention-for-jail-inmates-132938 https://curecurrent.com/trials/fosamprenavir-in-pts-with-hepatic-impairment-132939 https://curecurrent.com/trials/evaluation-of-cardiovascular-effects-of-smoking-cessation-in-hiv-patients-132940 https://curecurrent.com/trials/evaluation-of-re-entry-values-and-mindfulness-program-revamp-with-jail-inmates-132941 https://curecurrent.com/trials/jail-based-impact-of-crime-intervention-132942 https://curecurrent.com/trials/a-phase-i-trial-of-hiv-1-c4-v3-polyvalent-peptide-vaccine-in-hiv-1-infected-persons-132943 https://curecurrent.com/trials/treatment-perception-of-qd-once-a-day-dosed-kaletra-tablets-132944 https://curecurrent.com/trials/non-interventional-study-on-use-of-darunavir-with-ritonavir-in-clinical-practice-132945 https://curecurrent.com/trials/mentor-mothers-a-sustainable-family-intervention-in-south-african-townships-132946 https://curecurrent.com/trials/reducing-ethnic-health-disparities-motivating-hiv-latinos-to-quit-smoking-132947 https://curecurrent.com/trials/hiv-prevention-with-the-mentally-ill-132948 https://curecurrent.com/trials/determining-characteristics-and-behaviors-of-adolescent-women-regarding-hiv-risk-and-microbicide-trial-participation-132949 https://curecurrent.com/trials/raltegravir-based-antiretroviral-therapy-for-resistant-hiv-1-infection-132950 https://curecurrent.com/trials/efficacy-and-safety-of-tenofovir-plus-lamivudine-plus-efavirenz-regimen-as-first-line-antiretroviral-therapy-132951 https://curecurrent.com/trials/maraviroc-in-immunological-non-responder-inr-hiv-1-infected-subjects-132952 https://curecurrent.com/trials/impact-of-menstrual-cycle-on-antiretroviral-pharmacokinetics-in-hiv-infected-women-132953 https://curecurrent.com/trials/the-effects-of-nutritional-supplementation-and-drug-abuse-on-hiv-132954 https://curecurrent.com/trials/study-to-evaluate-switching-from-a-regimen-consisting-of-the-efavirenz-emtricitabine-tenofovir-disoproxil-fumarate-singl-132955 https://curecurrent.com/trials/drug-use-investigation-on-zithromac-azithromycin-in-hiv-patients-132956 https://curecurrent.com/trials/parent-provider-intervention-for-improving-medication-adherence-in-children-with-attention-deficit-hyperactivity-disorde-132957 https://curecurrent.com/trials/genotype-based-personalized-prescription-of-nevirapine-132958 https://curecurrent.com/trials/pharmacokinetic-interactions-between-telaprevir-and-un-boosted-atazanavir-132959 https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-calcium-carbonate-and-ferrous-fumarate-on-pharmacokinetics-of-dolutegravir-in-healthy-132960 https://curecurrent.com/trials/modified-directly-observed-therapy-for-improving-antiretroviral-therapy-adherence-in-people-with-hiv-132961 https://curecurrent.com/trials/safety-study-of-uc-781-vaginal-microbicide-132962 https://curecurrent.com/trials/a-study-to-assess-gw433908-fosamprenavir-containing-regimens-in-hiv-1-infected-subjects-132963 https://curecurrent.com/trials/a-network-dyad-hiv-prevention-intervention-for-idu-s-1-132964 https://curecurrent.com/trials/the-role-of-ampligen-in-strategic-therapeutic-intervention-sti-of-haart-132965 https://curecurrent.com/trials/safety-and-efficacy-of-ampligen-in-the-treatment-of-hiv-patients-failing-haart-132966 https://curecurrent.com/trials/evaluation-of-treatments-for-homeless-youths-132967 https://curecurrent.com/trials/adult-sexual-risk-behavior-among-women-with-a-history-of-childhood-sexual-abuse-132968 https://curecurrent.com/trials/share-safer-sex-counseling-program-for-changing-sexual-risk-behaviors-in-mexican-female-sex-workers-132969 https://curecurrent.com/trials/faster-identification-of-tb-and-evaluation-of-drug-resistance-in-hiv-infected-people-132970 https://curecurrent.com/trials/hiv-prevention-intervention-for-couples-132971 https://curecurrent.com/trials/analysis-of-changes-in-adipose-tissue-of-patients-with-lipoatrophy-hiv-infection-treated-with-nucleoside-thymidine-after-132972 https://curecurrent.com/trials/nutrition-intervention-in-drug-naive-hiv-infected-kenyan-women-and-their-children-132973 https://curecurrent.com/trials/family-planning-through-dairy-cooperatives-132974 https://curecurrent.com/trials/a-safety-and-efficacy-study-of-amdoxovir-in-hiv-1-treatment-experienced-subjects-132975 https://curecurrent.com/trials/reducing-hiv-risk-among-pregnant-women-in-drug-treatment-132976 https://curecurrent.com/trials/sleep-hiv-disease-progression-and-function-in-hiv-infected-children-and-adolescents-132977 https://curecurrent.com/trials/single-dermavir-immunization-in-hiv-1-infected-patients-on-haart-132978 https://curecurrent.com/trials/efficacy-and-safety-of-concomitant-use-of-nevirapine-and-rifampicin-with-hiv-tb-132979 https://curecurrent.com/trials/impact-on-t-cell-immune-activation-and-inflammation-of-triptolide-woldifii-in-hiv-infected-immunological-non-responders-132980 https://curecurrent.com/trials/lopinavir-r-monotherapy-versus-abacavir-lamivudine-and-lopinavir-r-for-limb-fat-recovery-in-persons-with-lipoatrophy-132981 https://curecurrent.com/trials/garlic-in-hyperlipidemia-caused-by-haart-132982 https://curecurrent.com/trials/progression-of-hiv-disease-under-low-dose-corticosteroids-132983 https://curecurrent.com/trials/adolescent-drug-and-hiv-prevention-in-south-africa-132984 https://curecurrent.com/trials/safety-and-efficacy-of-famciclovir-in-hiv1-positive-adults-with-recurrent-genital-herpes-132985 https://curecurrent.com/trials/clinical-trial-open-label-randomised-in-order-to-compare-the-quality-of-life-for-those-vih-patients-that-start-with-mono-132986 https://curecurrent.com/trials/safety-and-efficacy-of-kaletra-in-arv-therapy-experienced-patients-132987 https://curecurrent.com/trials/project-power-adapting-project-safe-reducing-std-hiv-risk-in-women-prisoners-132988 https://curecurrent.com/trials/db289-versus-tmp-smx-for-the-treatment-of-acute-pneumocystis-jiroveci-pneumonia-pcp-132989 https://curecurrent.com/trials/antiviral-therapy-plus-either-peripheral-stem-cell-or-umbilical-cord-blood-transplantation-in-treating-patients-who-are-132990 https://curecurrent.com/trials/motiv82change-an-hiv-prevention-study-for-young-latino-men-132991 https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-steady-state-tmc278-on-the-pharmacokinetics-of-a-single-dose-of-digoxin-132992 https://curecurrent.com/trials/a-study-to-assess-the-bioequivalence-of-darunavir-when-co-administrated-with-cobicistat-under-fed-and-fasted-conditions-132993 https://curecurrent.com/trials/switch-from-combivir-or-trizivir-to-truvada-mitochondrial-effects-132994 https://curecurrent.com/trials/alcohol-use-and-risky-sexual-behaviors-among-hiv-infected-subjects-in-kampala-uganda-132995 https://curecurrent.com/trials/prevention-of-varicella-zoster-virus-vzv-reactivation-in-hiv-positive-individuals-enrolled-in-a-prospective-immunogenici-132996 https://curecurrent.com/trials/an-automated-tailored-information-application-for-medication-health-literacy-132997 https://curecurrent.com/trials/double-method-comparative-study-in-order-to-predict-the-use-of-co-receptors-from-type-1-hiv-phenotypic-study-trofile-est-132998 https://curecurrent.com/trials/effects-of-2-initial-standard-antiretroviral-combinations-therapies-on-lipid-metabolism-132999 https://curecurrent.com/trials/a-phase-i-study-of-modified-vaccinia-virus-ankara-mva-b-in-healthy-volunteers-at-low-risk-of-hiv-infection-133000 https://curecurrent.com/trials/once-daily-antiretroviral-therapy-in-hiv-1-infected-patients-with-cd4-cell-counts-below-100-cells-mcl-133001 https://curecurrent.com/trials/topotecan-hydrochloride-in-treating-children-with-meningeal-cancer-that-has-not-responded-to-previous-treatment-133002 https://curecurrent.com/trials/a-study-comparing-4-doses-of-gw810781-versus-placebo-in-hiv-infected-patients-133003 https://curecurrent.com/trials/a-community-health-worker-delivered-hiv-sti-prevention-intervention-for-internally-displaced-women-in-leogane-haiti-133004 https://curecurrent.com/trials/safety-and-effectiveness-of-short-term-anti-hiv-drug-therapy-for-recent-hiv-1-infection-133005 https://curecurrent.com/trials/evaluation-of-the-performance-of-the-nitrate-reductase-and-resazurin-titre-assay-for-the-detection-of-mycobacterium-tube-133006 https://curecurrent.com/trials/a-study-to-compare-effectiveness-and-safety-of-darunavir-ritonavir-drv-rtv-800mg-100mg-once-daily-versus-drv-rtv-600mg-1-133007 https://curecurrent.com/trials/clinical-study-of-tuti-16-in-asymptomatic-hiv-1-infected-subjects-thymon-11001-133008 https://curecurrent.com/trials/genetic-determinants-of-the-metabolism-of-non-nucleoside-reverse-transcriptase-inhibitors-133009 https://curecurrent.com/trials/exploration-of-hiv-reservoirs-133010 https://curecurrent.com/trials/periodical-presumptive-treatment-for-the-control-of-gonococcal-infections-among-sex-workers-133011 https://curecurrent.com/trials/attitudes-and-beliefs-and-the-steps-of-hiv-care-133012 https://curecurrent.com/trials/reducing-hiv-safer-sex-skill-building-in-pregnant-drug-abusing-women-133013 https://curecurrent.com/trials/study-to-explore-safety-and-tolerability-of-fosamprenavir-with-or-without-ritonavir-in-combination-with-trizivir-or-comb-133014 https://curecurrent.com/trials/sgn-00101-in-preventing-anal-cancer-in-patients-with-hiv-who-have-anal-neoplasia-133015 https://curecurrent.com/trials/safety-and-immunogenicity-of-a-plasmid-hiv-vaccine-in-hiv-uninfected-adults-133016 https://curecurrent.com/trials/safety-and-immunogenicity-of-tbc-m4-a-mva-hiv-vaccine-alone-or-in-a-prime-boost-regimen-with-advax-dna-hiv-vaccine-133017 https://curecurrent.com/trials/safety-and-immunogenicity-of-a-modified-vaccinia-ankara-mva-hiv-vaccine-in-hiv-uninfected-adults-133018 https://curecurrent.com/trials/bms-275291-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-133019 https://curecurrent.com/trials/efficacy-of-raltegravir-in-a-large-urban-hiv-clinical-population-in-milan-133020 https://curecurrent.com/trials/safety-and-immunogenicity-study-of-2-investigational-preventive-hiv-vaccines-133021 https://curecurrent.com/trials/interleukin-12-following-chemotherapy-in-treating-patients-with-refractory-hiv-associated-non-hodgkin-s-lymphoma-133022 https://curecurrent.com/trials/combination-chemotherapy-with-or-without-monoclonal-antibody-therapy-in-treating-patients-with-previously-untreated-hiv-133023 https://curecurrent.com/trials/antiretroviral-sparing-concept-with-hiv-specific-t-cell-precursors-with-high-proliferative-capacity-phpc-133024 https://curecurrent.com/trials/role-of-hiv-on-glutathione-synthesis-and-oxidative-stress-133025 https://curecurrent.com/trials/influenza-vaccination-of-hiv-infected-pregnant-women-safety-and-immunogenicity-133026 https://curecurrent.com/trials/altretamine-and-etoposide-in-treating-patients-with-hiv-related-cancer-133027 https://curecurrent.com/trials/hiv-screening-in-the-emergency-department-setting-133028 https://curecurrent.com/trials/effect-of-an-integrase-inhibitor-on-the-latency-and-reservoir-of-hiv-1-133029 https://curecurrent.com/trials/pharmacokinetic-study-of-raltegravir-in-human-immunodeficiency-virus-hepatitis-c-virus-hiv-vhc-coinfected-patients-with-133030 https://curecurrent.com/trials/preliminary-evaluation-of-a-point-of-care-liver-function-test-133031 https://curecurrent.com/trials/drug-interaction-study-133032 https://curecurrent.com/trials/phase-ii-study-of-ags-004-as-an-immunotherapeutic-in-antiretroviral-therapy-art-treated-subjects-infected-with-hiv-133033 https://curecurrent.com/trials/folinic-acid-and-vascular-reactivity-in-hiv-133034 https://curecurrent.com/trials/study-to-investigate-the-hemodynamic-effects-of-single-dose-vardenafil-in-subjects-receiving-maraviroc-133035 https://curecurrent.com/trials/bryostatin-1-plus-vincristine-in-treating-patients-with-recurrent-or-refractory-hiv-related-lymphoma-133036 https://curecurrent.com/trials/a-comparison-of-body-fat-distribution-in-hiv-1-infected-patients-receiving-since-the-beginning-and-for-at-least-two-year-133037 https://curecurrent.com/trials/switching-the-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-or-protease-inhibitor-pi-to-maraviroc-in-hiv-subjects-133038 https://curecurrent.com/trials/typing-of-human-papilloma-virus-hpv-from-female-genital-warts-133039 https://curecurrent.com/trials/prevention-of-pregnancy-associated-malaria-in-hiv-infected-women-cotrimoxazole-prophylaxis-versus-mefloquine-133040 https://curecurrent.com/trials/study-of-hepatitis-c-virus-hcv-viral-kinetics-in-hiv-hcv-and-hcv-patients-133041 https://curecurrent.com/trials/clinical-study-of-tuti-16-in-hiv-1-infected-and-uninfected-subjects-133042 https://curecurrent.com/trials/kaletra-therapy-with-double-protease-inhibitors-133043 https://curecurrent.com/trials/interactions-between-artemether-lumefantrine-and-antiretrovirals-in-hiv-patients-with-uncomplicated-malaria-in-tanzania-133044 https://curecurrent.com/trials/hiv-and-hepatitis-care-coordination-in-methadone-treatment-133045 https://curecurrent.com/trials/safety-and-immunogenicity-study-of-tgaac09-a-gag-pr-rt-aav-hiv-vaccine-133046 https://curecurrent.com/trials/male-involvement-in-antenatal-care-and-the-prevention-programme-of-mother-to-child-transmission-of-hiv-in-uganda-133047 https://curecurrent.com/trials/a-clinical-trial-comparing-the-tolerability-of-etravirine-to-efavirenz-in-combination-with-2-nucleoside-nucleotide-rever-133048 https://curecurrent.com/trials/boosted-atazanavir-and-truvada-given-once-daily-baton-study-133049 https://curecurrent.com/trials/lower-extremity-splinting-to-manage-pain-and-sleep-disturbances-associated-with-hiv-aids-related-peripheral-neuropathy-133050 https://curecurrent.com/trials/safety-of-lopinavir-ritonavir-kaletra-in-hiv-hcv-co-infected-subjects-vs-baseline-liver-biopsy-metavir-score-133051 https://curecurrent.com/trials/randomized-control-trial-of-shang-ring-versus-forceps-guided-adult-male-circumcision-in-southwestern-uganda-133052 https://curecurrent.com/trials/study-of-human-papillomavirus-related-genital-pathology-among-hiv-positive-women-133053 https://curecurrent.com/trials/effectiveness-of-hepatitis-a-virus-vaccination-among-homosexual-males-at-risk-for-hepatitis-a-infection-133054 https://curecurrent.com/trials/accelerated-aging-hiv-infection-antiretroviral-therapies-133055 https://curecurrent.com/trials/patients-infected-with-hiv-since-more-than-10-years-with-a-plasma-viral-rna-400-copies-ml-in-the-absence-of-any-treatmen-133056 https://curecurrent.com/trials/utility-of-sputum-induction-and-novel-technologies-to-improve-tb-diagnosis-in-a-high-hiv-prevalence-primary-care-setting-133057 https://curecurrent.com/trials/use-of-incentives-to-engage-drug-users-in-hiv-therapy-133058 https://curecurrent.com/trials/raltegravir-therapy-for-women-with-hiv-and-fat-accumulation-133059 https://curecurrent.com/trials/a-study-of-trimetrexate-with-leucovorin-rescue-for-aids-patients-who-are-refractory-to-standard-therapies-for-pneumocyst-133060 https://curecurrent.com/trials/effects-of-mixed-exercise-regime-and-l-carnitine-supplementation-in-hiv-patients-on-haart-133061 https://curecurrent.com/trials/treatment-simplification-by-darunavir-ritonavir-800-100-mg-once-a-day-versus-a-triple-combination-therapy-with-darunavir-133062 https://curecurrent.com/trials/the-tolerance-of-hiv-infected-patients-with-herpes-group-virus-infections-to-oral-doses-of-fiau-133063 https://curecurrent.com/trials/safety-study-of-ibalizumab-subcutaneous-injection-in-healthy-volunteers-133064 https://curecurrent.com/trials/the-safety-and-effectiveness-of-fiac-in-the-treatment-of-cytomegalovirus-cmv-in-patients-with-aids-133065 https://curecurrent.com/trials/study-of-niacin-on-endothelial-function-in-hiv-infected-subjects-with-low-high-density-lipoprotein-cholesterol-levels-133066 https://curecurrent.com/trials/safety-and-immunogenicity-study-of-tgaac09-an-hiv-vaccine-in-an-adeno-associated-virus-aav-capsid-133067 https://curecurrent.com/trials/safety-and-immunogenicity-study-of-ad26-enva-and-ad35-env-hiv-vaccines-in-healthy-hiv-uninfected-adults-133068 https://curecurrent.com/trials/treatment-of-anemia-and-neutropenia-in-hiv-hcv-coinfected-patients-treated-with-pegylated-interferon-and-ribavirin-133069 https://curecurrent.com/trials/development-of-a-methamphetamine-early-intervention-133070 https://curecurrent.com/trials/study-on-immunopathogenesis-in-hiv-and-hepatitis-c-coinfection-133071 https://curecurrent.com/trials/mobile-phone-text-messaging-referral-133072 https://curecurrent.com/trials/tmc125hiv1083-swallowability-of-uncoated-200-mg-etravirine-tablets-in-hiv-1-infected-patients-133073 https://curecurrent.com/trials/reactogenicity-and-immunogenicity-of-cervico-vaginal-cn54gp140-hsp70-conjugate-vaccine-133074 https://curecurrent.com/trials/partner-specific-hiv-risk-reduction-intervention-for-drug-using-adolescents-133075 https://curecurrent.com/trials/an-open-label-trial-of-the-effect-of-valacyclovir-on-plasma-hiv-1-levels-among-hiv-1-seropositive-and-hsv-1-2-seronegati-133076 https://curecurrent.com/trials/comparative-tolerability-of-protease-inhibitors-133077 https://curecurrent.com/trials/trial-of-three-neonatal-antiretroviral-regimens-for-prevention-of-intrapartum-hiv-transmission-133078 https://curecurrent.com/trials/maraviroc-ccr5-antagonism-to-decrease-the-incidence-of-the-immune-reconstitution-inflammatory-syndrome-in-hiv-infected-p-133079 https://curecurrent.com/trials/an-evaluation-of-a-rapid-test-for-hiv-133080 https://curecurrent.com/trials/pharmacokinetic-interactions-between-buprenorphine-and-kaletra-lopinavir-ritonavir-133081 https://curecurrent.com/trials/buprenorphine-raltegravir-pharmacokinetic-interaction-study-133082 https://curecurrent.com/trials/tmc278-tidp15-c158-a-study-to-examine-the-safety-tolerability-and-pharmacokinetics-of-a-single-dose-or-three-successive-133083 https://curecurrent.com/trials/a-study-of-anti-hiv-monoclonal-antibody-kd-247-133084 https://curecurrent.com/trials/study-of-pennvax-b-gag-pol-env-electroporation-in-hiv-1-infected-adult-participants-133085 https://curecurrent.com/trials/a-multicentre-trial-of-second-line-antiretroviral-treatment-strategies-in-african-adults-using-atazanavir-or-lopinavir-r-133086 https://curecurrent.com/trials/a-study-to-examine-the-human-papillomavirus-types-exposure-in-women-from-southern-africa-and-brasil-133087 https://curecurrent.com/trials/non-interventional-study-of-celsentri-in-treatment-experienced-patients-with-ccr5-tropic-hiv-infection-133088 https://curecurrent.com/trials/immune-therapies-and-anti-hiv-therapy-withdrawal-in-controlling-viral-load-133089 https://curecurrent.com/trials/depo-medroxyprogesterone-acetate-dmpa-depo-provera-use-with-certain-anti-hiv-drugs-in-hiv-infected-women-133090 https://curecurrent.com/trials/hpmpc-cidofovir-peripheral-cmv-retinitis-trial-protocol-133091 https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-and-toxicity-of-the-combination-of-zidovudine-and-2-3-dideoxyinosine-didanosine-i-133092 https://curecurrent.com/trials/phase-ii-trial-of-sequential-chemotherapy-and-radiotherapy-for-aids-related-primary-central-nervous-system-lymphoma-133093 https://curecurrent.com/trials/the-safety-and-effectiveness-of-rifabutin-combined-with-clarithromycin-or-azithromycin-in-hiv-infected-patients-133094 https://curecurrent.com/trials/a-study-to-prepare-for-future-hiv-vaccine-studies-133095 https://curecurrent.com/trials/hiv-and-cardiovascular-risk-133096 https://curecurrent.com/trials/prevalence-of-hepatitis-c-virus-infection-in-hiv-infected-children-133097 https://curecurrent.com/trials/evaluation-of-treatment-for-mycobacterium-avium-complex-mac-infection-in-hiv-infected-patients-133098 https://curecurrent.com/trials/a-phase-i-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-200-mcg-of-gp120-cho-biocine-in-mf59-emulsion-vers-133099 https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-vaccine-sf-2-gp120-with-or-without-mtp-pe-mf59-adjuvant-133100 https://curecurrent.com/trials/voluntary-hiv-counseling-testing-and-medication-for-pregnant-women-to-prevent-mother-to-child-hiv-transmission-133101 https://curecurrent.com/trials/effect-of-tenofovir-disoproxil-fumarate-on-lipid-levels-in-hiv-infected-adults-on-stable-anti-hiv-drug-therapy-133102 https://curecurrent.com/trials/safety-and-effectiveness-of-administering-an-hiv-vaccine-in-the-groin-versus-the-arm-133103 https://curecurrent.com/trials/a-randomized-prospective-study-of-pyrimethamine-therapy-for-prevention-of-toxoplasmic-encephalitis-in-hiv-infected-indiv-133104 https://curecurrent.com/trials/safety-effectiveness-and-tolerability-of-ezetimibe-combined-with-statins-for-the-treatment-of-high-cholesterol-in-hiv-in-133105 https://curecurrent.com/trials/anti-hiv-medications-and-structured-treatment-interruptions-for-people-recently-infected-with-hiv-133106 https://curecurrent.com/trials/outcomes-of-anti-hiv-therapy-during-early-hiv-infection-133107 https://curecurrent.com/trials/directly-observed-therapy-in-hiv-infected-adolescent-focus-groups-133108 https://curecurrent.com/trials/long-term-follow-up-of-hiv-infected-patients-identified-during-early-infection-133109 https://curecurrent.com/trials/is-tuberculin-skin-testing-effective-in-screening-for-latent-tuberculosis-in-patients-with-hiv-133110 https://curecurrent.com/trials/antiretroviral-resistance-detection-by-ultrasensitive-pyrosequencing-of-the-hiv-1-genome-and-virological-response-to-ant-133111 https://curecurrent.com/trials/a-phase-ii-iii-trial-of-human-anti-cmv-monoclonal-antibody-msl-109-macrt-133112 https://curecurrent.com/trials/computer-assisted-tailored-cue-card-health-catch-study-133113 https://curecurrent.com/trials/drug-interactions-between-voriconazole-and-atazanavir-coadministered-as-atazanavir-ritonavir-in-healthy-participants-133114 https://curecurrent.com/trials/long-term-assessment-for-metabolic-cardiovascular-and-neurologic-problems-in-hiv-infected-patients-with-increased-cd4-ce-133115